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Abstract
N6-threonylcarbamoyl adenosine (t6A) is a universally conserved tRNA 
modification found at position 37 of tRNAs which decode ANN codons.  Structural
studies have implicated its presence as a requirement for the disruption of a U-
turn motif in certain tRNAs, leading to the formation of properly structured 
anticodon stem loop.  This structure is proposed to enhance the base pairing 
between U36 of tRNA and A1 of the codon which aids in translational frame 
maintenance.
Despite significant effort since its discovery in the 1970s the enzymes 
involved in its biosynthesis remained undiscovered.  Bioinformatic analysis 
identified two proteins as likely candidates for t6A synthesis, YrdC and YgjD.  
Subsequent gene knockout experiments in yeast were consistent with their 
involvement in t6A biosynthesis in vivo.  Furthermore, clustering between the 
bacterial genes ygjD, yeaZ and yjeE as well as the identification of a protein 
interaction network between YgjD, YeaZ, and YjeE suggested that YeaZ and 
YjeE might be involved in t6A biosynthesis.
The genes encoding ygjD, yeaZ, yrdC and yjeE were cloned from E. coli 
and the recombinant protein was purified.  Experiments analyzing the 
incorporation of [U-14C]-L-threonine and [14C]-bicarbonate (substrates previously 
indicated in its biosynthesis) into tRNA in the presence of these four proteins 
demonstrated the first reconstitution of the t6A pathway in vitro.  LC-MS analysis 
verified the formation of t6A, and these proteins were renamed TsaD (YgjD), TsaB
i
(YeaZ), TsaC (YrdC), and TsaE (YjeE).
Biochemical characterization of this pathway suggested that the formation 
of t6A proceeds through an unstable threonylcarbamoyl adenosine 
monophosphate (TC-AMP) intermediate, which is produced by TsaC from its 
substrates CO2, L-threonine and ATP.  To investigate this reaction in more detail a
coupled assay was developed, enabling sensitive detection of turn over.  TsaC is 
a promiscuous enzyme which readily accepts several amino acids as substrates. 
The formation of t6A  from TC-AMP is catalyzed by TsaD, TsaB, and TsaE.  Of 
these three proteins only TsaD is universally conserved suggesting it is the 
protein catalyzing the transfer of the threonylcarbamoyl moiety to A37 of tRNA.  
This transfer is not promiscuous as only TC-AMP serves as an efficient substrate
for t6A formation.  Structural investigation of these proteins are consistent with the
formation of a single protein complex potentially alleviating issues with the 
reactivity and instability of TC-AMP.
ii
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Glossary
Δsua5 tRNA: Total transfer ribonucleic acid from yeast cells lacking the tsaC 
gene
ψ (nucleoside): Pseudouridine
μg: Microgram
μL: Microliter
μM: Micromolar
6 (nucleoside): N6-threonylcarbamoyl adenosine
6x Histidine: Hexahistidine
7 (nucleoside): 7-methylguanosine
A (amino acid): Alanine
A (nucleotide): Adenosine-5'-diphosphate
A (ribosome): Aminoacyl site of ribosome
A340: Absorbance at 340 nanometers
A600: Optical density at 600 nanometers
AA: Amino acid
aaRS: Aminoacyl transfer ribonucleic acid synthetase
Acceptor stem: Transfer ribonucleic acid, site of aminoacylation
ADP: Adenosine-5'-diphosphate
Ala: Alanine
ALS: Anticodon stem and loop
AMP: Adenosine-5'-monophosphate
x
Arg: Arginine 
ArgS: Arginyltransfer ribonucleic acid synthase
Asp: Aspartic acid
Asn: Asparagine
ATP: Adenosine-5'-triphosphate
BME: 2-mercaptoethanol
BP: Nucleotide base pair
BPB: Bromophenol blue
B. subtilis:  Bacillus subtilis
C (nucleotide): Cytidine-5'-triphosphate
CAMP: Cationic antimicrobial peptides
CCA: Cytosine-cytosine-adenine
cm: Centimeter
CTP: Cytidine-5'-triphosphate
CV: Column volume
Cys: Cysteine
Cys-tRNACys: Cysteine specific transfer ribonucleic acid, aminoacylated with 
cysteine
D (nucleotide): Dihydrouridine
D stem and loop: Transfer ribonucleic acid stem loop containing dihydrouridine 
modification
DEPC: Diethylpyrocarbonate
Dicer: Endoribonuclease which cleaves double stranded ribonucleic acids
xi
DNA: Deoxyribonucleic acid
DNase: Deoxyribonuclease
dNTPs: Deoxyribonucleotide triphosphates
DPM: Disintegration per minute, units to express radioactivity
DTT: Dithiothreitol
E (ribosome): Exit site of ribosome
E. coli: Escherichia coli
EDTA: Ethylenediaminetetraacetate
eEF-1: Eukaryotic elongation factor 1
EF-TU: Elongation factor thermo unstable
elF2: Elongation factor 2
eIF4: Elongation factor 4
eIF4A: Elongation factor 4A
FPLC: Fast protein liquid chromatography
G (nucleotide): Guanosine-5'-triphosphate
g6A: N6-glycinylcarbamoyl adenosine
GC-AMP: Glycinylcarbamoyl adenosine monophosphate
Gcn2P: Eukaroytic elongation factor 2 protein kinase
GDP: Guanosine-5'-diphosphate
GlcNAc: N-acetylglucosamine
Gln: Glutamine
Glu: Glutamic acid
xii
Gly: Glycine
GTP: Guanosine-5'-triphosphate
HEPES:  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid
His: Histidine
HPLC: High pressure liquid chromatography
hn6A: N6-hydroxynorvalylcarbamoyl adenosine
HNC-AMP: Hydroxynorvalylcarbamoyl adenosine monophosphate
H. sapiens: Homo sapiens
I (nucleotide): Inosine
IEX: Ion exchange chromatography
Ile: Isoleucine
IPTG: Isopropyl-β-D-thiogalactopyranoside
K: Lysine
kV: Kilovolt
L (volume): Liter
LB: Luria Broth
LC: Liquid chromatography
LC-MS: Liquid chromatography mass spectrometry
Leu: Leucine
Lys: Lysine
M: Molar
m6A: N6-methyladenosine
xiii
m1G: 1-methylguanosine
m5U: 5-methyl uridine
MES:  2-(N-Morpholino)ethanesulfonic acid
Met: Methionine
metRS: Methionyl-tRNA synthetase
Met-tRNAiMet: Methionine aminoacylated, methionine specific transfer ribonucleic
acid 
min: Minute
mg: Milligram
mm: Millimeter
mM: Millimolar
MprF: transfer ribonucleic acid dependent aminoacyl transferase
mRNA: Messanger ribonucleic acid
MS: Mass spectrometry
ms2t6A:  2-methylthio-N6-threonylcarbamoyl adenosine
M. thermoautotrophicus: Methanothermobacter thermoautotrophicus
MurNAc: N-acetylmuramic acid
N (amino acid): Asparganine
NADH: Nicotinamide adenine dinucleotide, reduced form
NAD+: Nicotinamide adenine dinucleotide, oxidized form
Ni-NTA: Nickel nitrilotriacetic acid
nm: Nanometer
xiv
NMR: Nuclear magnetic resonance spectroscopy
NT: Nucleotide
N-terminus: The amino terminus of a peptide
NTPs: Ribonucleotide triphosphates
P (ribosome): Peptidyl site of ribosome
PAGE: Polyacrylamide gel electrophoresis
PCR: Polymerase chain reaction
PEI-Cellulose: Polyethyleneimine cellulose
Phe: Phenylalanine
Phosphoseryl-tRNACys: Phosphoserine aminoacylated, cysteine specific 
transfer ribonucleic acid
pmol: Picomol
PMSF: Phenylmethylsulfonyl flouride
ppGpp: 5'-diphosphate 3'-diphophate guanosine
Pi: Phosphate
PIPES: 1,4-Piperazinediethanesulfonic acid
PPi: Pyrophosphate
pppGpp: 5'-triphosphate 3'-diphosphate guanosine
Pro: Proline
RCF: Relative centrifugal force
RelA: Ribosome-associated ppGpp synthase
S (nucleoside):  5-methylaminomethyl-2-thiouridine
xv
SEC: Size exclusion chromatography
SepCysS: O-phospho-L-seryl-tRNA:Cys-tRNA synthase 
SpoT: 5'-diphosphate 3'-diphophate guanosine hyrdolase and synthase
SUMO: Small Ubiquitin-like Modifer Protein
R (amino acid): Arginine
RelA: Ribosome-associated ppGpp synthase
RNA: Ribonucleic acid
RNase: Ribonuclease
RNase P: Ribonuclease which cleaves the 5' end of transfer ribonucleic acid
RNase Z: Ribonuclease which cleaves the 3' end of transfer ribonucleic acid
s6A: N6-serinylcarbamoyl adenosine
S nucleoside: 5-methylaminomethyl-2-thiouridine
SC-AMP: Serinylcarbamoyl adenosine monophosphate
S. cerevisiae: Saccharomyces cerevisiae
SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Ser: Serine
T (nucleoside): Thymine
t6A: N6-threonylcarbamoyl adenosine
TC-AMP: Threonylcarbamoyl adenosine monophosphate
Thr: Threonine
TLC: Thin layer chromatography
TobZ:  O-carbamoyltransferase
xvi
Tris-HCl: Tris(hydroxymethyl)aminomethane hydrochloride
tRNA: Transfer ribonucleic acid
tRNAAla: Alanine specific transfer ribonucleic acid
tRNAAsp: Aspartic acid specific transfer ribonucleic acid
tRNALys(UUU): Lysine specific transfer ribonucleic acid, codon UUU 
tRNAPhe: Phenylalanine specific transfer ribonucleic acid
tRNAfMet : Methionine specific transfer ribonucleic acid used for initiation
Trp: Tryptophan
tsaB: N6-threonylcarbamoyl adenosine gene B
TsaB: N6-threonylcarbamoyl adenosine protein B
tsaC: N6-threonylcarbamoyl adenosine gene C
TsaC: N6-threonylcarbamoyl adenosine protein C
tsaD: N6-threonylcarbamoyl adenosine gene D
TsaD: N6-threonylcarbamoyl adenosine protein D
tsaE: N6-threonylcarbamoyl adenosine gene E
TsaE: N6-threonylcarbamoyl adenosine protein E
T stem and loop: tRNA stem loop containing thymine-pseudouridine-cytosine 
(TΨC) modification
Tyr: Tyrosine
U (Nucleotide): Uridine-5'-triphosphate
UNN: Uridine, any nucleotide, any nucleotide
Urea-PAGE: Urea polyacrylamide gel electrophoresis
xvii
UTP: Uridine-5'-triphosphate
UTR: Untranslated region
Val: Valine
wY: Wybutosine
X (nucleoside): 3-(3-amino-3-carboxypropyl)uridine
XC: Xylene cyanol
XC-AMP: Derivative of N6-threonylcarbamoyl adenosine where X = any amino 
acid
yeaZ: N6-threonylcarbamoyl adenosine gene B
YeaZ: N6-threonylcarbamoyl adenosine protein B
ydiE: Bacillus subtilis N6-threonylcarbamoyl adenosine gene D
ydiC: Bacillus subtilis N6-threonylcarbamoyl adenosine gene B
ygjD: N6-threonylcarbamoyl adenosine gene D
YgjD: N6-threonylcarbamoyl adenosine protein D
yjeE: N6-threonylcarbamoyl adenosine gene E
YjeE: N6-threonylcarbamoyl adenosine protein E
yrdC: N6-threonylcarbamoyl adenosine gene C
YrdC: N6-threonylcarbamoyl adenosine protein C
xviii
1.0 Introduction
1.1 Transfer Ribonucleic Acids
tRNA Structure
Transfer ribonucleic acids (tRNAs) are small single stranded 
ribonucleotides which are essential to protein biosynthesis.  Through interactions 
between both nucleic acids and proteins they serve as adapter molecules in 
translation.  
Canonical tRNAs consist of 73-94 ribonucleotides.  Their secondary 
structure is often represented by a clover-leaf comprised of four stems and 3 
loops (D, T, anticodon and acceptor stems and D, T, anticodon loops) (Figure 1).  
The acceptor stem contains 7-9 base pairs which include the phosphorylated 5' 
terminal nucleotide, the 3' terminal nucleotide, and a cytosine-cytosine-adenine 
(CCA) terminus (appended to the 3' terminus of the tRNA).  The D stem is 
composed of 4-6 base pairs ending in a 4-12 nucleotide loop containing 
dihydrouridine (D).  The anticodon stem is composed of 6 base pairs ending in a 
7 nucleotide loop which contains the anticodon.  The T stem is composed of 4-5 
base pairs ending in a 7 nucleotide loop which contains the sequence thymine-
pseudouridine-cytosine (TΨC) (1).  In some tRNAs there is an additional variable
loop between the T and anticodon stems which is typically 4-23 nucleotides in 
length (2).  
The universally conserved tertiary structure of tRNAs is the result of 
coaxial stacking of RNA helices (3, 4) (Figure 2).  This structure is formed as a 
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result of the acceptor stem stacking with the T stem and the D stem stacking with
the anticodon stem.  All tRNAs share this common tertiary structure which allows 
for their transfer between the peptidyl and aminoacyl sites of the ribosome.
Canonical Function
Transfer ribonucleic acids are adapter molecules which bridge the gap 
between the genetic information storage of nucleic acids and the amino acid 
sequence of proteins.  They accomplish this role through the addition of an 
amino acid (AA) to their 3' terminus (aminoacylation) by aminoacyl tRNA 
synthetases (aaRS).  Specific interactions between tRNAs and aminoacyl tRNA 
synthetases confer specificity of tRNA aminoacylation by amino acids.  These 
aminoacylated-tRNAs subsequently serve as activated intermediates in protein 
translation, allowing for the transfer of an amino acid to a growing polypeptide 
chain.  After aminoacylation, a tRNA is delivered to the ribosome with the aid of 
elongation factors (EF-TU in bacteria, eEF-1 in eukaroytes) (5).  At the ribosome 
the aminoacyl-tRNA interacts with messenger RNA (mRNA) via a three base pair
interaction between the codon of mRNA and the anticodon of tRNA.  Once the 
appropriate tRNA is bound, the ribosome catalyzes the transfer an amino acid 
from its 3' terminus to the growing polypeptide chain (Figure 3).
tRNA Maturation
tRNA maturation is a complex and necessary sequence of events which 
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convert the pre-tRNA (the initial transcription product of a tRNA gene by an RNA 
polymerase) to a fully functional mature tRNA.  Initially, RNA polymerase 
transcribes a pre-tRNA consisting of the canonical nucleobases cytosine (C), 
adenine (A), uracil (U), and guanine (G).  This pre-tRNA may contain introns 
which are spliced out by tRNA endonucleases in archaea and eukaryotes (6-8).  
In bacteria, introns contained in the tRNA gene are self-splicing through the 
formation of a catalytically active RNA structure (a ribozyme) (9-11).  Additionally, 
the 5' and 3' termini of the pre-tRNA are cleaved by RNaseP and RNaseZ 
respectively (8, 12, 13).  Subsequently, this cleaved transcript is further modified 
by the addition of a CCA terminus to the 3' end by a nucleotidyl transferase.  
Before the tRNA can become fully mature it is exported to the cytoplasm (in 
eukaroytes) where it undergoes extensive nucleoside modification (14-16).  The 
order of maturation, and the steps required for maturation, are not universally 
conserved.
Nucleoside Modification
Nucleoside modification is prevalent in tRNAs, with over 100 modifications
being characterized to date (17, 18).  Typically 10-25% of nucleosides are 
modified in tRNA (19).  These are broadly grouped into two categories, simple or 
hyper-modifications (Figure 4) (20), and all are derived from the canonical 
nucleobases A, U, C, and G (21).  Simple modifications typically involve relatively
minor chemical modifications such as methylations, reductions, and 
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isomerizations, and are generally formed in a single enzymatic step.  Hyper-
modification typically imparts substantial changes in the nucleotide structure, and
involves multiple enzymatic steps to complete.  The importance of modified 
nucleosides can be highlighted by the abundance of genes involved in 
modifications of nucleotides (~1% of an organisms genome) (22).
Function of Modified Nucleobases
 The function of many modifications are yet to be elucidated but are 
proposed to play roles in translation, tRNA identity and/or stability/folding.  
Modifications occurring in the main body of tRNAs often influence stability or 
folding properties.  For example, the loss of T54 leads to a reduction in 
thermostability of tRNAPhe and tRNAfMet, with the Tm decreasing by 2-6 °C (23, 24).
The loss of m1A9 in tRNALys leads to an alternative structure (25) and the lack of 
Ψ can destabilize helices (26).  The biological consequences of these structural 
changes are not entirely understood, but emerging evidence suggests the lack of
modifications leads to degradation of the tRNA (27).  Modifications at various 
positions influence the identity of tRNAs.  For example, lysidine at position 34 of 
tRNAIle prevents misacylation by methionyl-tRNA synthetase (metRS) (28), and 
m1G37 of tRNAAsp prevents misacylation by arginyltransfer ribonucleic acid 
synthase (ArgS) (29).
An abundance of these modifications occur in or around the anticodon 
stem loop (ASL), typically improving translational fidelity and efficiency.  
4
Modifications found in the ASL frequently effect tRNA function by regulating 
codon-anticodon interactions.  Positions 34 and 37 are the most frequently 
modified tRNA positions, often serving to regulate wobble-base pair interactions. 
These interactions are discussed in detail in the following section.  
Degeneracy of the Genetic Code and the Importance of the ASL
Degeneracy of genetic code refers to the fact that each codon is specific 
for an amino acid (or encodes a stop) but some amino acids are coded for by 
more then one codon (Table 1).  The limited number of tRNAs available for 
translation (typically about 40 per organism vs 64 codons) leads to the 
requirement that some tRNA recognize more then one codon (21, 30).  
These observations led Francis Crick to propose the wobble hypothesis in 
1966 (31).  The wobble hypothesis suggested that the first two base pairings of 
the codon to the anticodon would be canonical Watson-Crick base pairs and 
would provide coding specificity, while the third nucleotide of the codon (wobble 
position) would determine the number of codons that a tRNA would recognize.  
Specifically, if the wobble position was a C or A only the Watson-Crick base pair 
would be possible.  Conversely, if the wobble position was a U or G more then 
one base pairing would be possible (G with C or U, U with A or G).  These 
properties would allow for some tRNAs to recognize more then one codon, 
solving the problems associated with the limited number of tRNAs available for 
decoding.
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The first tRNA sequenced (Saccharomyces cerevisiae tRNAAla) was found 
to contain an inosine at the wobble position.  This was important as the 
replacement of an adenosine with inosine substantially increases the number of 
codons which can be recognized (A with U vs I with A , U, or C) consistent with 
the wobble hypothesis, and encouraging the investigation of the importance of 
nucleoside modification in the ASL (21, 27).
In the 50 years since Crick's proposal many exciting discoveries on the 
importance of modification of the ASL have been observed, leading to an 
“expanded wobble hypothesis” (Table 2) (21).  This hypothesis includes 
modifications occurring at position 34 (wobble) and 37 (conserved purine 
adjacent to the anticodon) of the anticodon stem loop.  
The wobble position is commonly modified in order to expand recognition 
and selectivity while maintaining the required ASL architecture for translation.  
Inosine, lysidine, 5-methylene uridine derivatives, 2-thiouridine derivatives, and 
the 5-oxyuridine derivatives have all been to shown to play critical roles in wobble
base pairing (Figure 5).  It is now understood that approximately 30-40% of all 
codon recognition occurs through wobble base pairing, underlying its importance 
in translation (21).
The conserved purine 37 adjacent to the anticodon has also been shown 
to be critical to translation.  Its modification has been proposed to be linked to 
base pairing between the first base of the codon and the third of the anticodon.  
Specifically, N6-isopentyladenosine (or derivatives) are found in tRNA which 
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decode UNN codons while t6A (or derivatives) are found in tRNA which decode 
ANN codons (where N = any nucleobase).  It is proposed that these modified 
bases are necessary to increase the stability of U36-A1 or A36-U1 base pairings 
while codon-anticodon pairings involving a C36-G1 or G36-C1 would be stable 
enough to not require modification of the 3' adjacent purine (21, 30).
Regulation a Non-canonical Function of tRNA
Recently, tRNAs have been shown to perform numerous additional 
functions in both prokaryotes and eukaroytes (Figure 6) (27, 32, 33).  Non-
aminoacylated (uncharged) tRNAs have important roles in signaling and 
regulation of metabolic and cellular processes.  Numerous examples of this have 
been reported and include the stringent response, the T box control system, 
activation of the protein kinase Gcn2p, accumulation of tRNA in the P site of the 
ribosome, and the formation of tRNA fragments.
The stringent response is a global regulatory system which is mediated by 
the production of alarmone, 5'-diphosphate 3'-diphophate guanosine (ppGpp), 
and 5'-triphosphate 3'-diphosphate guanosine (pppGpp).  In E. coli, the 
production of ppGpp is mediated by two enzymes, RelA and SpoT.  RelA is a 
ribosome-associated ppGpp synthase which uses uncharged tRNAs as effector 
molecules to activate its synthesis of pppGpp and ppGpp from guanosine-5'-
triphosphate (GTP) or guanosine-5'-diphosphate (GDP) and adenosine 5'-
triphosphate (ATP).  The enzyme SpoT is a dual ppGpp hyrdolase/synthase 
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which is currently poorly understood.  ppGpp then serves as an effector molecule
binding between the ω and β' subunits of RNA polymerase to downregulate 
global transcription levels (34).
The T box control system is found in many gram negative bacteria such as
Bacillus subtilis (B. subtilis).  The T box regulatory system is controlled by the 
binding of tRNA to specific, conserved regions in the 5' untranslated region (UTR)
of mRNA known as T box leader sequences.  The T box leader sequence acts as
a riboswitch which prevents translation in the presence of an aminoacyl-tRNA 
while allowing translation in the presence of an uncharged tRNA through the 
formation of terminator or anti-terminator structures, respectively.  Numerous 
amino acid related genes are controlled by this mechanism including the 
isoleucyl-tRNA synthetase in Actinobacteria (33).
In eukaroytes, uncharged tRNAs serve as effector molecules to activate 
the protein kinase Gcn2p.  Once activated this kinase phosphorylates serine 51 
of the α subunit of eIF2.  eIF2 is a protein involved in translation intiation 
(specifically the binding of GTP and Met-tRNAiMet) which upon phosphorylation is 
downregulated, lowering the overall level of gene translation (35).
In both eukaryotes and bacteria uncharged tRNAs can accumulate in the 
P site of the ribosome.  This accumulation inhibits protein synthesis.
tRNAs regulate gene expression through the production of tRNA 
fragments.  These fragments can function as other small non-coding RNA (small 
interfering RNA, micro RNA, etc.) which bind mRNA for degradation.  tRNA 
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fragments have also been suggested to interfere with translational initiation 
through displacement of eIF4/eIF4A from capped and uncapped mRNA (36, 37). 
Recent studies have also indicated that tRNAs and their fragments can play a 
critical role in regulating apoptosis in the cell (38).   Cytochrome c induced 
caspase-9 activation leads to apoptosis of the cell through a process known as 
the intrinsic pathway.  Microinjections of tRNA have been shown to reduce this 
activation while injection of tRNA specific RNase (leading to the formation of 
tRNA fragments) enhances it.  Taken together it is likely that tRNA binds 
cytochrome c, preventing caspase-9 activation while tRNA fragments enhance 
caspase-9 activation by cytochrome c.
Aminoacyl-tRNA as substrates in cellular processes
Aminoacyl-tRNAs serve as substrates for a variety of cellular processes 
beyond their canonical role in translation.  An example of this is the non-
ribosomal addition of amino acids to proteins targeting them for degradation.  
The transfer of an amino acid to the N-terminus of proteins by an aminoacyl-
tRNA transferase can drastically influence the rate of degradation of the protein.  
In β-galactosidase the addition of amino acids can influence the stability of the 
protein significantly (half lives of 3 minutes to over 20 hours).  This trend of 
protein instability due to an N-terminal amino acid is called the N-end rule and 
has been observed in bacteria, plants, fungi and mammals (39).
Additionally, aminoacyl-tRNAs are used in the non-ribosomal formation of 
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peptides bonds in peptidoglycan, a critical structural element of bacterial cell 
walls.  Peptidoglycan is a polymer of N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc).  The lactyl groups of MurNAc are further modified 
with the substitution of small penta stem peptides.  These penta stem peptides 
are then either directly cross-linked or cross-linked with an additional amino acid. 
The crosslinking of penta stem peptides with additional amino acids is dependent
upon aminoacylated-tRNAs as a substrate for aminoacyl-tRNA ligases (40).
Aminoacyl-tRNAs serve as substrates in the modification of 
phosopholipids in the cell membrane.  One example of this is a response to 
cationic antimicrobial peptides (CAMPs) which have strong affinities for 
negatively charged bacterial lipids.  Specifically, the MprF enzyme aminoacylates
anionic phospolipids with L-alanine or L-lysine using aminoacylated tRNAs as 
substrates.  This aminoacylation imparts positive charges preventing the 
association between bacterial lipids and CAMPs (41).  Furthermore aminoacyl-
tRNA are substrates for the production of antibiotics (valanimycin, pacidamycin, 
cyclopeptide synthesis, etc.), precursors for other aminoacyl-tRNA 
(phosphoseryl-tRNACys conservsion to Cys-tRNACys by SepCysS), and the 
formation of tetrapyrrole (42, 43).
1.2 N6-threonylcarbamoyl adenosine
N6-threonylcarbamoyl adenosine (t6A) is a nucleoside modification found in
the ASL at position 37 of tRNAs which decode ANN codons, and is one of the 15 
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known universally conserved modifications.  It is essential in most bacterial 
systems while being dispensable in some eukaroytic systems (44).  Despite not 
being essential in model eukaryotic systems its absence leads to severe growth 
defects.  
Radioactive substrate incorporation examined in the 1970s showed its 
biosynthesis was dependent upon threonine, bicarbonate and ATP (45-50) 
(Figure 7).  Numerous structural and biochemical studies (51-58) have provided 
a great deal of insight into the function of t6A.  These works were consistent with 
t6A improving translational fidelity by promoting cross-strand stacking of t6A37 and 
A38 with the first position of the codon and preventing across-the-loop base 
pairing of U33-A37, allowing for a properly structured ASL (Figure 8) (53-56).  This 
hypothesis is supported by in vivo work, as yeast mutants deficient in t6A have 
increased rates of initiation and frame maintenance defects (51, 52).  
Additionally, t6A modification appears to be required for tRNALys translocation (59, 
60).
Elucidation of RNA modification pathways is a particularly challenging 
problem.  This is primarily due to the lack of obvious phenotypes of modification 
deficient strains and the difficulty of biochemical assays used to detect these 
modifications.  Despite t6A being found in all domains of life, the discovery of its 
biochemical precursors over 30 years ago, and the presence of obvious 
phenotypes in deficient strains, the proteins involved in the biosynthesis pathway 
had remained undiscovered. 
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Bioinformatic analysis identified two protein families which were potential 
candidates for t6A biosynthesis, YgjD (TsaD) and YrdC (TsaC).  These proteins 
were of unknown function and universally conserved.  Significantly, the YgjD and 
YrdC protein families were found fused in proteins catalyzing chemistry similar to 
what is expected in t6A biosynthesis and were listed by Galperin et al. (61) as 
among the top ten proteins of unknown function in need of functional 
characterization.  An example of YgjD and YrdC domain fusion is the O-
carbamoyltransferase TobZ (Figure 9).  TobZ carbamoylates the antibiotic 
tobramycin to form nebramycin.  This is accomplished by the formation of a 
carbamoyladenylate by a YrdC (TsaC) like domain.  This intermediate is 
subsequently channeled to a Kae1 (TsaD) like domain, where carbamoyl transfer
occurs (Figure 10) (62).  Yeast knock out strains of sua5 (tsaC) or kae1 (tsaD) 
genes confirmed the involvement of these proteins in t6A biosynthesis as the loss
of these genes lead to the absence of t6A in vivo (Figure 11) (51, 52).
In addition to t6A, numerous related nucleoside modifications have been 
identified (Table 3, Figure 12).  These modifications differ from t6A by either the 
substitution of threonine with another amino acid ( N6-glycinylcarbamoyl 
adenosine,  N6-hydroxynorvalylcarbamoyl adenosine) or by additional chemical 
appendages in addition to t6A (2-methylthio-N6-threonylcarbamoyl adenosine,  N6-
methyl-N6-threonylcarbamoyl adenosine).  The similarity of these modifications 
with t6A suggested that some common biochemical precursors and/or enzymes 
may be involved in their synthesis.  These modifications have only been 
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identified in tRNA with little to no characterization on their effects and 
biosynthesis occurring to date.
Specific Aims
The overall objectives of this work were to identify the proteins involved in 
t6A biosynthesis, elucidate the chemical mechanism of its formation, and 
determine the function of the proteins involved in its synthesis. 
1.  Identification of Proteins Involved in the Biosynthesis of t6A
The goal of these investigations was to determine both the proteins 
involved in t6A biosynthesis as well as the minimum protein requirements for its 
formation.
2. Elucidation of Structural Interactions of t6A Proteins
The goal of these experiments was to elucidate the structural interactions 
of the proteins involved in t6A biosynthesis.
3.  Characterization of the t6A Biosynthetic Pathway, Mechanism and 
Substrate Specificity
The goal of these experiments was to determine the minimum substrate 
requirements for t6A formation, the chemical route its formation, and the substrate
specificity of the enzymes involves in its biosynthesis.
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2.0 Materials and Methods
2.1 General
Instrumentation
Ultraviolet-visible (UV-VIS) spectrophotometery was carried out using a 
Varian Cary 100 or Beckman DU-520 spectrophotometer.  High pressure liquid 
chromatography (HPLC) was accomplished using an Agilent 1100 HPLC.  
Phosphorimaging experiments were conducted using a GE Typhoon Trio+.  
Scintillation counting was completed using either a Beckman LS6500 Liquid 
Scintillation Counter or a Hidex 300 SL.  Analytical SDS-PAGE and Urea-PAGE 
analysis was performed using the Mini Protean III apparatus from BioRad.  
Nitrocellulose transfer was performed using a BioRad Trans-Blot Semi-Dry 
Transfer Cell.  Preparative Urea-PAGE utilized a Dan-Kar Corp vertical gel 
apparatus.  Centrifugation was performed using an Avanti J-20 XP centrifuge, 
Eppendorf 5430R, LabNet Spectrafuge 16M Microcentrifuge, or Sorvall RC 5C 
Plus.  Mass spectrometric experiments were conducted using a Thermo LTQ 
Orbitrap.  Polymerase chain reaction (PCR) utilized an Applied Biosystems 2720 
Thermal Cycler.  Agarose gel electrophoresis was performed using a GeneMate 
horizontal gel system and was visualized using a Transilluminator FBTIV-88 from 
Fisher Scientific.  Lyophilization was performed using a Labconco Centrivap 
Concentrator equipped with a Labconco Centrivap Cold Trap.  The vacuum pump
utilized for lyophilization was an Oerlikon Leybold Vacuum (model trivac P 2,5 E).
Protein ion exchange chromatography (IEX) was performed on a GE Healthcare 
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Lifesciences Akta Fast Protein Liquid Chromatography (FPLC) utilizing a GE 
Healthcare HiTrap Q 1 mL column.
Bacterial Cell Lines
E. coli NovaBlue (endA1 hsdR17 (r
K12
– m
K12
+) supE44 thi-1 recA1 gyrA96 
relA1 lac F′[proA+B+ lacIqZΔM15::Tn10] (TetR)) cells were purchased from 
Novagen.  E. coli BL21(DE3) (F– ompT hsdSB (rB– mB–) gal dcm (DE3) cells were 
purchased from Novagen.  Cells were grown in Luria Broth (LB) at 37 °C unless 
otherwise noted.  When necessary, LB was supplemented with kanamycin (50 
μg/mL), ampicillin (100 μg/mL), isopropyl-β-D-thiogalactopyranoside (IPTG, 1 
mM), and ZnCl2 (0.5 μM).  When plating bacteria Fisher LB Agar was used.
Enzymes
Nuclease P1 from Penicillium citrinum and Phosphodiesterase I from 
Crotalus adamanteus venom were purchased from Sigma Aldrich as lyophilized 
powders.  These enzymes were dissolved into the manufacturer recommended 
buffer and stored at -20 °C.  Proteinase K was purchased from Sigma Aldrich in 
buffered solution and was stored at -20 °C.  Alkaline phosphatase, T4 DNA 
Ligase, and Pfu Ultra DNA Polymerase (Agilent) were purchased as solutions 
from Fisher Scientific and were stored at the manufacturer recommended 
temperature.  Restriction enzymes were purchased from Fermentas and stored 
at -20 °C.  Lysozyme was purchased as a lyophilized powder from Fisher and 
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stored at -20 °C.  FactorXa was obtained from New England Biolabs and stored 
at -20 °C.
Chemicals and Reagents
All reagents, salts, buffers, and enzymes were obtained from Fisher 
Scientific unless otherwise noted.  All solutions were prepared using millipore  
(18.2 MΩ•cm resistivity) water.  Oligonucleotides were purchased from Integrated
DNA Technologies.  Polyethyleneimine cellulose (PEI-Cellulose) thin layer 
chromatography (TLC) plates were purchased from SiliCycle.  [U-14C]-L-threonine
and sodium [14C]-bicarbonate were purchased from Moravek.  Alpha and gamma 
[32P]-adenosine triphosphates were purchased from Perkin Elmer or MP 
Biomedical.  Sodium [32P]-pyrophosphate (PPi) was purchased from MP 
Biomedical.  D-[U-13C]-Glucose and [15N]-ammonium chloride were purchased 
from Sigma Aldrich.  Nickel nitrilotriacetic acid (Ni-NTA) affinity resin was 
purchased from Sigma Aldrich or Qiagen.  Centrifugal filtration units were 
obtained from Amicon.  All solutions containing RNA utilized diethyl 
pyrocarbonate (DEPC) treated water.  DEPC was added to millipore treated 
water at a final concentration of 0.1% (volume/volume) and allowed to react 
overnight before autoclaving to produce DEPC treated water.  Size exclusion 
chromatography (SEC) standards were purchased from Sigma Aldrich.  
Adenosine, guanosine, cytidine, and uridine triphosphates were purchased from 
Sigma Aldrich.  Bradford reagent was obtained from BioRad.  The QuikChange 
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site directed mutagenesis kit was obtained from Agilent.  PCR purification kits 
were obtained from Qiagen.  The FactorXa/LIC cloning kit was obtained from 
Novagen.  Pyrophosphate reagent was purchased from Sigma Aldrich.  
EconoSafe liquid scintillation cocktail was purchased from RPI.  D,L-
hydroxynorvaline was obtained from Sigma Aldrich.  A special thanks to 
Christopher Lima (Sloan-Kettering Institute) for the generous gift of the plasmid 
pSMT3 and pULP1 (63), Valérie de Crécy-Lagard (University of Florida) for the 
generous gift of plasmids containing tsaD (pBY216.1), tsaC (pBY215.1), and 
tsaC mutants K53A (pYC103.2), R110A (pYC101.1), K50A (pYC103.1) and R52A
(pYC102.2), bulk tRNA isolated from wild type S. cerevisiae, bulk tRNA isolated 
from Saccharomyces cerevisiae (S. cerevisiae) with a sua5 (tsaC) gene deletion,
John Perona for the plasmid containing T7 Polymerase (pT7-911Q), and Paul 
Agris for H. sapiens tRNALys -3(UUU) ASL.
2.2 Preparation of Proteins and RNA
Construction of Expression Constructs
PCR-based cloning of the E. coli tsaB, tsaE, and prmC genes was carried 
out using genomic DNA from the E. coli K12 cell line using the primers listed in 
Table 4.  The resulting constructs were named pCDII29 (tsaB), pCDII30 (tsaE), 
and pCDII140 (prmC).  Construct names were assigned as plasmid (p), Chris 
Deutsch (CD), lab note book (roman numeral) and page number.  E. coli genomic
DNA was isolated as described by Syn et al. (64).  PCR reactions contained 500 
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ng of genomic DNA, 200 μM deoxyribonucleotides (dNTPs), 50 picomol (pmol) 
primers, 1X Pfu Ultra buffer (supplied by the manufacturer), and 2.5 units of Pfu 
Ultra DNA polymerase in a final volume of 50 μL.  A three step PCR 
thermocycling protocol was utilized: 1) 94 °C for 3 minutes; 2) 30 cycles of 
denaturation at 94 °C for 1 minutes, annealing at 50 °C for 1 minutes, and 
extension at 72 °C for 2 minutes; 3) 72 °C for 3 minutes.  The PCR products 
were then gel purified (1% agarose), the DNA isolated (Qiagen PCR purification 
kit) and ligated into a FactorXa/LIC vector (Novagen) as described by the 
manufacturer.  
The tsaC mutants K53A, R110A, K50A and R52A were cloned into 
FactorXa/LIC vectors using the plasmids pYC103.2, pYC101.1, pYC103.1 and  
pYC102.2 respectively using the primers listed in Table 4.  The PCR reactions 
were performed as previously described with the substitution of plasmid for 
genomic DNA.  The resulting tsaC mutant constructs were renamed pCDIII24.1 
(K53A), pCDIII24.2 (R110A), pCDIII24.3 (K50A), and pCDIII24.4 (R52A).  
The tsaD gene was cloned from plasmid pBY216.1 using the primers 
listed in Table 4.  Cloning was performed as described in (63).  The resulting 
construct was named pCDI74 (SUMO-TsaD).  
Site directed mutagenesis of plasmid pBY215.1 to obtain the tsaC mutant 
N141A was performed using the QuikChange protocol using the primers in Table 
4.  The resulting construct was named pCDIII24.5.  
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DNA Sequencing, Purification, Extraction and Restriction Digestion
DNA sequencing was carried out by the OHSU core sequencing laboratory
to confirm the primary structures of all constructs.  Plasmid preparations were 
performed using a Qiagen MiniPrep or MaxiPrep using the manufacturer 
recommended protocol.  Plasmids were transformed into E. coli NovaBlue cells 
for isolation of plasmid DNA, or E. coli BL21(DE3) for production and isolation of 
recombinant proteins.  Competent cells were produced using CaCl2 as described 
by Nishimura (65).  Transformations of plasmids into E. coli  were performed by 
placing competent cells on ice for 5 minutes, adding 1 μL plasmid (500 ng/μL), 
followed by a 30 minute incubation on ice.  Cells were subsequently incubated at 
42 °C for 45 seconds before being placed back on ice for an additional 5 
minutes.  LB (500 μL) was added to the cell/plasmid mixture and the solution was
incubated at 37 °C for one hour before plating.  DNA extraction from agarose was
performed using a Qiagen PCR purification kit as described by the manufacturer. 
Restriction digestion was performed using restriction enzymes from Fermentas 
using the manufacturer recommended protocols.  DNA ligation was performed 
using T4 DNA ligase using the manufacturer supplied protocols.
Overproduction and Purification of Recombinant, Affinity-tagged Proteins
Cultures of transformed BL21(DE3) cells containing plasmids to produce 
TsaC, TsaB, TsaE, TsaD, PrmC, ULP, T7 polymerase, TsaC K53A, TsaC R110A, 
TsaC K50A, TsaC R52A, and TsaC N141A were grown overnight at 25 °C until an
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optical density at 600 nm (A600) of 2–3 was obtained.  LB was supplemented with 
50 μg/L kanamycin (100 μg/L ampicillin for T7 Polymerase).  Cells were pelleted 
(2,500 relative centrifugal force (RCF), 20 minutes, 4 °C) and resuspended in an 
equal volume of LB containing 50 μg/L kanamycin (100 μg/L ampicillin for T7 
Polymerase).  After a one hour recovery period at 20 °C (TsaD) or 37 °C (all 
others), IPTG was added to a final concentration of 1.0 mM, and cultures were 
grown for an additional 4 hours (TsaD 16 hours in the presence of 0.5 μM ZnCl2). 
Cells were then pelleted (5000 RCF, 15 minutes, 4 °C) and resuspended to 250 
mg cells/mL buffer.  The resuspension buffer contained 100 mM Tris-HCl (pH 
8.0), 2.0 mM 2-mercaptoethanol (BME), 1.0 mM phenylmethylsulfonyl flouride 
(PMSF) and 100 mM KCl (300 mM KCl, TsaD).  T7 polymerase preparations also
included protease inhibitor cocktail (Roche) at the manufacturer specified 
concentrations.  Lysozyme (0.25 mg/mL) was then added, and the resulting 
solutions incubated for 30 minutes at 37 °C.  Cells were subsequently lysed by 
three cycles of freezing/thawing at -80 °C/ 37 °C.  In order to reduce the viscosity
of the cell lysate DNase (10 μg/mL) was added and incubated at 37 °C for 30 
minutes.  The solutions were centrifuged (15,000 RCF, 20 minutes, 4 °C), and 
the supernatants applied to Ni-NTA columns which had been equilibrated with 10 
column volumes (CV) equilibration buffer.  Equilibration buffer was comprised of 
100 mM Tris-HCl (pH 8.0), 2.0 mM BME, and 100 mM KCl (300 mM KCl, TsaD).
The columns were washed sequentially with 7 CV of equilibration buffer, 3 
volumes of equilibration buffer containing 20 mM imidazole, 4 volumes of 
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equilibration buffer containing 30 mM imidazole, followed by elution with 
equilibration buffer containing 200 mM imidazole.  Fractions containing purified 
protein were concentrated using Millipore Centrifugal Filter units to 500 μL and 
subjected to dialysis (Slyde-a-lyzer, Pierce) against 4 L of 100 mM Tris-HCl (pH 
8.0) and 100 mM KCl (300 mM KCl TsaD) overnight at 4 °C.
The fusion proteins were cleaved overnight at room temperature using 1 
μg FactorXa per mg of TsaC, TsaB, TsaE, or PrmC according to the 
manufacturer's protocol to remove the N-terminal affinity fusion peptide.  SUMO-
TsaD was cleaved using ULP1 (10 μg/mg) using published protocols (63).  After 
ULP1 cleavage TsaD became unstable, so the tag was subsequently retained for
all future experiments.  The cleaved proteins were then applied to a Ni-NTA 
column which had been equilibrated with 10 column volumes of 100 mM Tris-HCl
(pH 8.0), 100 mM KCl (300 mM for TsaD), and 2 mM BME.  Proteins were eluted 
from the column using equilibration buffer.  After elution the protein pools were 
concentrated (Millipore Centrifugal Filter units), combined with an equal volume 
of glycerol, and stored at −80 °C for future use.  When necessary proteins were 
subjected to ion exchange chromatography for a final polishing step using a 
HiTrap Q (GE Healthcare Life Sciences) 5x1 mm column.  This was 
accomplished by placing up to 10 mg of protein in a 1 mL solution containing 100
mM Tris-HCl (pH 8.0), 100 mM KCl (300 mM for TsaD), and 1 mM BME.  A salt 
gradient was subsequently run up to 1 M KCl over the course of 30 minutes 
using an Akta FPLC with a flow rate of 1 mL/min.  Fractions were pooled and 
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assessed for purity by SDS-PAGE.  Protein concentrations were based on the 
Bradford dye-binding procedure (66) or UV-VIS spectrometry.  Extinction 
coefficients for proteins were determined using ProtParam from ExPASy (67).
Construction of tRNA Templates for in vitro Transcription
The templates for producing E. coli tRNALys(UUU), tRNAIle(CAU), 
tRNAIle(GAU), and Methanothermobacter thermoautotrophicus (M. 
thermoautotrophicus) tRNAGln(CUG) transcripts were produced via a Klenow 
extension reaction as described by Sherlin (68) with the oligonucleotides listed in 
Table 5.  E. coli tRNAThr(GGU) template was produced using a plasmid based 
method (pCDI147).  Plasmid pCDI147 was produced by the ligation of six 
oligonucleotide pieces (Table 5) using T4 DNA ligase as described by the 
manufacturer.  The plasmid was then transformed into E. coli NovaBlue cells and
purified using a Qiagen Plasmid Maxi Preparation kit according to the 
manufacturer supplied protocols.  
The ligated DNA fragment was subsequently digested with BamHI/HindIII 
before ligation into similarly treated pUC18.  Plasmid was subsequently 
linearized using MvaI to allow for run-off transcription.  The template 
corresponding to the anticodon stem loop of H. sapiens tRNALys -3(UUU) with a 
U27-A43 replacement of G27-C43 to improve stability was produced by annealing 
two oligonucleotides (Table 5).  This was accomplished by heating equimolar 
sense and antisense oligonucleotides at 90 °C for 5 minutes and then allowing 
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them to cool at room temperature for an hour.
RNA Transcription and Purification
Transcription reactions to produce a 17-nucleotide RNA corresponding to 
the anticodon stem-loop of tRNALys (17-mer RNA) or the full-length tRNAs were 
run for four hours at 37 °C in 80 mM HEPES (pH 7.4), 2.0 mM spermidine, 24 
mM MgCl2, 2.0 mM ribonucleotide triphosphates (NTPs), 3 μM template, and 2.5 
μg/mL of T7 polymerase.  The RNA products generated in the transcription 
reactions were precipitated by the addition of 0.1 volume 8.0 M ammonium 
acetate, 3 volumes of 100% ethanol, and cooling at −80 °C for 30 minutes, then 
pelleted by centrifugation at 15,000 RCF for 30 minutes at 4 °C, and 
resuspended in 50 mM HEPES (pH 7.4), 2.0 mM EDTA.  The solutions were 
mixed 1:1 with formamide, heated at 90 °C for 5 minutes, and snap cooled on ice
before being purified via Urea-PAGE electrophoresis (20% for ASL RNA, 10% for
full length tRNA).  The RNA was extracted by cutting the excised band from the 
Urea-PAGE gel, slicing it into 1 cm cubes, followed by adding 10 mL HEPES (pH 
7.4) 2 mM EDTA per 1 g of gel. This suspension was then placed at 4 °C with 
agitation overnight.  The soluble portion of the suspension was then precipitated 
as previously described, and resuspended in 50 mM HEPES (pH 7.4) 2 mM 
EDTA.  
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2.3 Biochemical Investigation of t6A Biosynthesis
tRNA Precipitation Assays
The extent of in vitro tRNA modification with t6A was monitored using a 
tRNA precipitation assay.  Reactions contained radioactive [U-14C]-L-threonine, 
[U-14C]-threonylcarbamoyl adenosine monophosphate (TC-AMP) or [14C]- 
bicarbonate.  The precipitation of tRNA was accomplished by the addition of 0.1 
volumes 8 M ammonium acetate and 3 volumes 100% ethanol before incubation 
at -80 °C for 30 minutes, resulting in a tRNA suspension.  These tRNA 
suspensions were then transferred to separate Whatman GF/B filters.  To ensure 
transfer of the precipitate the microcentrifuge tubes containing the reaction were 
washed with an additional 1 mL of 70% cold ethanol and this fluid was placed on 
the same filters as the original suspension.  After transfer the filters were washed 
with 2 L of cold 70% ethanol and dried using filtration.  The dried filters were 
combined with 5 mL of RPI EconoSafe counting cocktail and the radioactivity 
quantified by liquid scintillation counting.
Protein Requirements of t6A Formation
Reactions contained 20 μM TsaB, 20 μM TsaC, 20 μM TsaD, 20 μM TsaE, 
10 mM ATP, 100 mM Tris-HCl (pH 8), 300 mM KCl, 5.0 mM DTT, 20 mM MgCl2, 1
μM ZnCl2, 1 mM MnCl2, 1 μM CaCl2, and 50 μM tRNA.  The tRNAs used were E. 
coli tRNALys(UUU), M. thermoautotrophicus tRNAGln(CUG), E. coli tRNAThr(GGU), 
the ASL of H. sapiens tRNALys-3(UUU), bulk tRNA isolated from a S. cerevisiae 
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Δsua5 knockout, or bulk tRNA isolated from S. cerevisiae.  When measuring the 
incorporation of [U-14C]-L-threonine the reactions also contained 50 mM sodium 
bicarbonate and 50 μM [U-14C]-L-threonine (100,000 DPM/assay).  Reactions 
measuring the incorporation of [14C]-bicarbonate contained 100 μM added 
sodium [14C]-bicarbonate (200,000 DPM/assay) and 10 mM L-threonine.  
Reactions were then terminated at indicated time points and the radioactive 
incorporation into tRNA quantified as described above.
RNA Modification of tRNAIle(CAU) and tRNAIle(GAU)
RNA modification of in vitro transcribed tRNAIle(CAU) and tRNAIle(GAU) 
was carried out in reactions containing 50 μM tRNAIle(CAU) or tRNAIle(GAU), 5 
μM TsaB, 5 μM  TsaC, 5 μM TsaD, 5 μM TsaE, 5 mM L-threonine, 5 mM sodium 
bicarbonate, 10 mM ATP, 100 mM Tris-HCl (pH 8.0), 300 mM KCl, 20 mM MgCl2, 
1 mM MnCl2, 1 μM ZnCl2 and and 5 mM DTT at 37 °C for 20 minutes.  To monitor
the extent of labeling reactions were run in parallel containing 5 mM [U-14C]-L-
threonine (250,000 DPM).  After the reaction tRNA was phenol/chloroform 
extracted, precipitated as described above, and then resuspended in 50 mM 
HEPES (pH 7.4), 2 mM EDTA.  This solution was snap frozen on dry ice before 
subsequent use.  Reactions containing [U-14C]-L-threonine were then terminated 
at indicated time points and the radioactive incorporation into tRNA quantified as 
described above.
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pH Optimization of t6A Enzyme Kinetics
Reactions containing 10 μM TsaB, 10 μM TsaC, 10 μM TsaD, 10 μM TsaE, 
300 mM KCl, 30 μM [U-14C]-L-threonine (100,000 DPM/assay), 10 mM sodium 
bicarbonate, 2 mM ATP, 50 mM MES, 50 mM MOPS, 50 mM Tris (pH 6-9 as 
indicated), 50 μM bulk tRNA isolated from a S. cerevisiae Δsua5 knockout, 1 mM 
DTT, and 0.5 mM MgCl2 were reacted at 37 °C for 30 minutes before termination 
and the radioactive incorporation into tRNA quantified as described above.
[U-14C]-Threonylcarbamoyl-AMP Incorporation Into tRNA 
Reactions containing 100 mM Tris-HCl (pH 8.0), 300 mM KCl, 10 mM 
bicarbonate, 0.5 mM MgCl2, 5 mM DTT, and 50 μM Δsua5 tRNA were incubated 
for 20 minutes at  37 ºC before ethanol precipitation.  Reactions also contained 
20 μM TsaB, 20 μM TsaC, 20 μM TsaD, 20 μM TsaE,  2 mM ATP, 30 μM [U-14C]-
L-threonine (100,000 DPM/assay), and [U-14C]-TC-AMP (100,000 DPM/assay) as
indicated.  Reactions were then terminated at indicated time points and the 
radioactive incorporation into tRNA quantified as described above.
Carbamoyl Adenosine Derivatives Incorporation Into tRNA
Reactions containing 100 mM Tris-HCl (pH 8.0), 300 mM KCl, 150 μM 
added [14C]-bicarbonate (1,000,000 DPM, approximately 163 μM due to 
dissolved carbonates), 10 mM ATP, 20 μM TsaB, 20 μM TsaC, 20 μM TsaD, 20 
μM TsaE, 0.5 mM MgCl2, 200 μM Δsua5 tRNA, and 10 mM amino acid (either L-
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threonine, L-serine, glycine, or D,L-hydroxynorvaline) were incubated for 20 
minutes at 37 °C.  Reactions were then terminated and the radioactive 
incorporation into tRNA quantified as described above.
High Pressure Liquid Chromatography of Carbamoyl Adenosine 
Monophosphates Produced by TsaC
HPLC of various carbamoyl adenosine monophosphate derivatives was 
performed using a Supelco Discovery HS C18 (250 × 2.1 mm, 5 μM) column with
a mobile phase of 10 mM ammonium acetate (pH 6.0, Buffer A) and acetonitrile 
(Buffer B) using a flow rate of 0.3 mL/min.  After a 5 minute hold with Buffer A a 
linear gradient with acetonitrile (100:0 to 60:40 over 20 minutes) was applied.  
Reactions were subjected to centrifugal filtration (Millipore centrifugal filter units, 
10 kDa cutoff) to remove TsaC and quench the reaction before HPLC analysis.  
The concentration of carbamoyl adenosine monophosphates was determined by 
the production of a standard curve using ATP.  ATP areas were compared to 
carbamoyl adenosine monophosphates assuming identical extinction 
coefficients.
Steady State Kinetics of TC-AMP Production
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 20 mM sodium 
bicarbonate, 0.5 mM MgCl2, and 20 μM TsaC were reacted at 37 °C for 5-30 
minutes then analyzed by HPLC as previously described.  Reactions also 
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contained 50 μM-50 mM L-threonine and 10 mM ATP when analyzing L-
threonine kinetics or 10 mM L-threonine and 100 μM-10 mM ATP when analyzing
ATP kinetics.
TsaC Mutant Analysis
Relative activities of TsaC mutants were determined by using HPLC as 
mentioned previously.  Specific conditions used for these assays were 50 mM 
MOPS (pH 7.4), 50 mM KCl, 10 mM L-threonine, 10 mM sodium bicarbonate, 0.5
mM MgCl2, 10 mM ATP, and 100 μM TsaC mutant.  The TsaC mutants tested 
were K53A, R110A, K50A, N141A, and R52A.
Analysis of ATP Formation by TsaC
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 0.5 mM MgCl2, 
100 μM TC-AMP, 20 mM pyrophoshphate, and 20 μM TsaC were reacted at 37 
°C for 20 minutes.  When investigating the reverse reaction using phosphate 
MOPS was replaced with 50 mM sodium phosphate (pH 7.4) and pyrophosphate 
was excluded.  Reactions were analyzed by HPLC as previously described.
Thin Layer Chromatography Analysis of [32P]-Phosphate Derivatives
TLC was performed using PEI-Cellulose plates which had been pre-run 
using water and allowed to dry before use.  Reactions analyzing ATP co-products
contained 5 μM TsaC, 5 μM TsaB, 5 μM TsaD, and 5 μM TsaE, 40 μM 
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tRNALys(UUU), 50 mM sodium bicarbonate, and 50 μM L-threonine as indicated.  
Reactions also included 100 mM Tris-HCl (pH 8.0), 300 mM KCl, 5.0 mM DTT, 
100 μM α-[32P]-ATP (10,000 DPM), 20 mM MgCl2, 1 μM ZnCl2, 1 mM MnCl2, 1 μM
CaCl2.  The reactions were run for 20 minutes at 37 ºC before a 1 μL aliquot was 
spotted on a PEI-Cellulose plate.  When analyzing TsaC's conversion of TC-AMP
to ATP reactions contained 50 μM TC-AMP, 10 μM TsaC, 50 mM MOPS (pH 7.4),
50 mM KCl, 0.5 mM MgCl2, and 50 μM [32P]-PPi or [32P]-Pi (10,000 DPM).  [32P]-
Pi was produced by the treatment of [32P]-PPi with alkaline phosphatase using 
the manufacturer supplied protocol.
Experiments were analyzed by spotting 1 μL of sample 1 cm from the 
bottom of the TLC plate.  After the spots had dried developing was accomplished 
through the use of a 0.5 M potassium phosphate (pH 3.5) mobile phase.  After 
the developed plates had dried the radioactive distribution of products was 
analyzed by phosphorimaging.  This was accomplished by exposing phosphor 
storage screens to the TLC plate for four hours.  When possible radioactive 
products were directly compared to standards.
[U-14C]-TC-AMP Purification
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 2 mM ATP, 0.5 
mM MgCl2,100 μM TsaC, 20 mM sodium bicarbonate, and 100 μM [U-14C]-L-
threonine were incubated at 37 ºC for 20 minutes and subsequently fractionated 
using HPLC.  HPLC parameters for fractionation of TC-AMP were the same as 
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as previously described for carbamoyl adenosine derivatives.  The peak 
corresponding to TC-AMP (retention time 20 minutes) was subsequently 
collected and snap frozen on dry ice.  The purified peak was lyophilized by speed
vacuum and stored at -80 ºC.
Mass Spectrometric Analysis of t6A
Reactions containing 20 μM TsaB, 20 μM TsaC, 20 μM TsaD, 20 μM TsaE, 
10 mM ATP, 100 mM Tris-HCl (pH 8), 300 mM KCl, 5.0 mM DTT, 20 mM MgCl2, 1
μM ZnCl2, 1 mM MnCl2, 1 μM CaCl2, 50 mM sodium bicarbonate, 10 mM L-
threonine, and 50 μM E. coli tRNALys(UUU) were incubated at 37 °C for 30 
minutes before phenol/chloroform extraction and ethanol precipitation.  After 
precipitation the tRNA was resuspended in water to a concentration of 1.8 μg/mL.
In order to produce individual nucleosides from the tRNA it was 
sequentially treated with Nuclease P1, phosphodiesterase, and alkaline 
phosphatase.  Nuclease P1 treatment was performed by adding 0.1 volumes 0.1 
M ammonium acetate (pH 5.3) and 5 μg Nuclease P1/1 mg tRNA.  This reaction 
was incubated for four hours at 50 °C.  Phosphodiesterase treatment was 
performed by adding 0.1 volume of 1 M ammonium bicarbonate (pH 7.8) and 
0.05 units of phosphodiesterase/1 mg of tRNA.  This reaction was incubated for 
four hours at 37 °C.  Lastly, alkaline phosphatase treatment was completed by 
adding 20 units of alkaline phosphatase and incubating for 2 hours at 37 °C.
This treated reaction mixture was analyzed by LC-MS on a Supelco 
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Discovery HS C18 (250 × 2.1 mm, 5 μM) with a mobile phase of 10 mM 
ammonium acetate (pH 6.0):acetonitrile (linear gradient of 95:5 to 60:40 over 20 
minutes) with a flow rate of 0.3 mL/min.  Mass analysis utilized an LTQ Orbitrap 
operating in the positive mode; spray voltage 4.00 kV; capillary temperature 300 
°C; capillary voltage 49; tube lens voltage 100.
Mass Spectrometric Analysis of Carbamoyl Adenosine Monophosphate 
Derivatives
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 20 mM sodium 
bicarbonate, 2 mM ATP, 0.5 mM MgCl2, 10 μM TsaC and 10 mM amino acid (L-
threonine, D,L-hydroxynorvaline, L-serine or glycine) were reacted at 37 °C for 
20 minutes.  These reaction mixtures were then spin filtered to remove TsaC and 
quench the reaction (Millipore centrifugal filter units, 10 kDa cutoff).  Reactions 
were subsequently analyzed by HPLC as previously described or LC-MS.  LC-
MS analysis used a Supelco Discovery HS C18 (250 × 2.1 mm, 5 μM) with a 
mobile phase of 10 mM ammonium acetate (pH 6.0):acetonitrile (linear gradient 
of 100:0 to 60:40 over 30 minutes) with a flow rate of 0.3 mL/min.  Mass analysis 
utilized an LTQ Orbitrap operating in the negative mode; spray voltage 2.5 kV; 
capillary temperature 300 °C; capillary voltage -17; tube lens voltage -107.  
Phosphorylation of t6A Proteins
Reactions containing 625,000 DPM γ[32P]-ATP, 100 mM Tris-HCl (pH 8.0), 
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300 mM KCl, 1 mM MgCl2,  25 mM sodium bicarbonate, and 25 mM L-threonine 
and when indicated 50 μM Δsua5 tRNA, 50 μM 6x histidine tagged TsaD, 50 μM 
6x histidine tagged TsaC, 50 μM 6x histidine tagged TsaB and 50 μM 6x histidine 
tagged TsaE, were incubated at 37 ºC for 20 minutes and subsequently loaded 
onto a Ni-NTA column which had been equilibrated with 100 mM Tris-HCl (pH 
8.0) and 300 mM KCl.  The reactions were subsequently washed with 20 column 
volumes equilibration buffer and then eluted in 4 column volumes of equilibration 
buffer containing 200 mM imidazole.  Fractions eluted in imidazole were 
concentrated using a Amicon centrifugation filter unit (10 kDa cutoff) and 
analyzed for radioactivity using liquid scintillation counting.  This was 
accomplished by adding approximately 100 μL of concentrated protein solution 
into 5 mL RPI EconoSafe counting cocktail.
Coupled Assay to Determine Pyrophosphate Production by TsaC
The TsaC catalyzed conversion of ATP to pyrophosphate was analyzed by 
UV-VIS spectroscopy.  The coupled assay was performed as described by Sigma
Aldrich with two notable exceptions.  First, the total volume of the assay was 
reduced from 2.95 mL to 137.5 μL, without affecting the concentration of 
components involved in the coupled assay.  Second, the temperature of the 
reaction was monitored at 37 °C instead of 30 °C.  
Reactions contained 50 mM MOPS (pH 7.4), 50 mM KCl, 10 mM 
bicarbonate, 50 μM – 20 mM amino acid (L-threonine, L-serine, D,L-
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hydroxynorvaline, glycine, L-alanine, L-valine), 1 mM ATP, 10 μM TsaC, 45 mM 
imidazole (pH 7.4), 5 mM citrate, 0.1 mM EDTA, 2 mM MgCl2, 0.2 mM MnCl2, 
0.02 mM CoCl2, 0.8 mM NADH, 12 mM Fructose-6-phosphate, 5 mg/mL bovine 
serum albumin, 5 mg/mL sugar stabilizer, 0.5 units/mL pyrophosphate dependent
phosphofructokinase, 7.5 units/mL aldolase, 5 units/mL glycerophosphate 
dehydrogenase, and 50 units/mL triosephosphate isomerase.  Reactions were 
analyzed at 37 °C from 0-20 minutes.
When analyzing kinetic parameters for ATP the reactions contained 50 mM
MOPS (pH 7.4), 50 mM KCl, 10 mM bicarbonate, 45 mM imidazole (pH 7.4), 5 
mM citrate, 0.1 mM EDTA, 2 mM MgCl2, 0.2 mM MnCl2, 0.02 mM CoCl2, 0.8 mM 
NADH, 12 mM Fructose-6-phosphate, 5 mg/mL bovine serum albumin, 5 mg/mL 
sugar stabilizer, 0.5 units/mL pyrophosphate dependent phosphofructokinase, 7.5
units/mL aldolase, 5 units/mL glycerophosphate dehydrogenase, 50 units/mL 
triosephosphate isomerase, 10 mM L-threonine, 50 μM - 20 mM ATP, and 10 μM 
TsaC.  Reactions were analyzed at 37 °C from 0-20 minutes.
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 10 mM 
bicarbonate, 45 mM imidazole (pH 7.4), 5 mM citrate, 0.1 mM EDTA, 2 mM 
MgCl2, 0.2 mM MnCl2, 0.02 mM CoCl2, 0.8 mM NADH, 12 mM Fructose-6-
phosphate, 5 mg/mL bovine serum albumin, 5 mg/mL sugar stabilizer, 0.5 
units/mL pyrophosphate dependent phosphofructokinase, 7.5 units/mL aldolase, 
5 units/mL glycerophosphate dehydrogenase, 50 units/mL triosephosphate 
isomerase, and 10 μM - 20 mM pyrophosphate were analyzed at 37 °C from 0-20
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minutes to determine the rate of NADH oxidation by the coupled enzymes.
The rate of TsaC pyrophosphate formation was determined using the following 
equation:
ΔA340/min Actual = (ΔA340/min Sample)-(ΔA340min Background)
Δ[NADH]/min = (ΔA340/min Actual)/(6220-M)
ΔPPi/min = -(Δ[NADH]/min)*(1 mol PPi/2 mol NADH)
Carboxythreonylation of Proteins
Reactions contained 50 mM MOPS (pH 7.4), 50 mM KCl, 2 mM ATP, 0.5 
mM MgCl2, and either 10 mM L-threonine, 105 μM [14C]-bicarbonate (200,000 
DPM/assay) or 30 μM [U-14C]-L-threonine (200,000 DPM/assay), 25 mM sodium 
bicarbonate.  N-terminal 6x histidine proteins were included when mentioned at 
the following concentrations, 100 μM TsaC, 10 μg other proteins (PrmC, TsaB, 
TsaE, TsaD).  After a 30 minute incubation at 37 °C reactions were washed using 
a 10 kDa cut off spin filter before liquid scintillation counting.  Washing entailed 
concentrating the assay components to 50 μL, discarding the flow through, 
adding buffer containing 50 mM MOPS (pH 7.4) and 50 mM KCl to a volume of 
500 μL.  This process was repeated a total of 6 times for a 1,000,000 fold 
effective dilution of radioisotopes.  
An aliquot from each sample was run on SDS-PAGE, transferred to a 
nitrocellulose membrane, and developed overnight for analysis by 
phosphorimaging.  Nitrocellulose transfer was accomplished by soaking 4 pieces 
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of filter paper in transfer buffer comprised of 25 mM Tris-HCl (pH 8.3), 192 mM 
glycine, 1.3 mM SDS, and 20% methanol for 5 minutes.  Subsequently a 
“transfer sandwich” was created by placing 2 pieces of wet filter paper on the 
anode of a semi-dry transfer apparatus, followed by a nitrocellulose membrane, a
SDS-PAGE gel, and 2 additional pieces of filter paper.  The semi-dry transfer 
apparatus was operated under a constant current of 30 mA and overall transfer 
of protein was monitored by transfer of the ladder to the membrane and was > 
90%.  Additional spots were placed over the ladder and corners of nitrocellulose 
membrane for orientation.
Carboxythreonylation of DNA
Reactions containing 50 mM MOPS (pH 7.4), 50 mM KCl, 5 mM ATP, 0.5 
mM MgCl2, 50 μM TsaC, 5 mM sodium bicarbonate, 50 μM [U-14C]-L-threonine 
(200,000 DPM), and either 25.9 μM E. coli tRNALys(UUU) template DNA or 10 μg 
E. coli genomic DNA were incubated at 37 °C for 30 minutes.  Reactions were 
then either purified using gel electrophoresis (agarose 1%) or precipitated by the 
addition of 3 volumes 100% ethanol and 0.1 volumes 8 M ammonium acetate 
before a 30 minute incubation at -80 °C.  Excised gel pieces were placed in 5 mL 
of liquid scintillation cocktail before being heated at 90 °C for 30 minutes to 
liberate DNA from the agarose.  Precipitated DNA was washed extensively with 
70% cold ethanol before resuspension in 100 μL of water.  The 100 μL DNA 
solutions were then placed in 5 mL of liquid scintillation cocktail.  Subsequently, 
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liquid scintillation counting was performed to determine if the DNA had been 
carboxythreonylated.
Protein Interactions (SDS-PAGE)
The TsaD, TsaC, TsaE, and TsaB proteins were tested pairwise for binding 
interactions.  In each test one protein was 6x histidine tagged and the other 
untagged as indicated.  Proteins were present at 20 μM each in a solution of 100 
mM Tris-HCl (pH 8.0), 300 mM KCl, and 2 mM BME (Buffer A), in a final volume 
of 100 μL.  After incubating for 20 minutes at room temperature the solution was 
added to 1 mL of Ni-NTA (pre-equilibrated with Buffer A) and exhaustively 
washed with Buffer A (at least 10 volumes).  The bound proteins were then eluted
from the column with a solution of Buffer A + 200 mM imidazole.  Fractions were 
pooled and concentrated back to 100 μL using 10 kDa centrifugal filter units 
(Amicon).  Reactions were then analyzed by SDS-PAGE.
Production of [U-13C, U-15N] and [U-15N] TsaC
Cultures of BL21(DE3) cells containing pBY215.1 (TsaC) were grown 
overnight in LB at room temperature until an A600 of 2–3 was obtained.  Cells 
were pelleted (2,500 RCF, 4 °C) and resuspended in an equal volume of M9 
minimal media.  
M9 minimal media was comprised of 47.74 mM Na2HPO4, 22.06 mM 
KH2PO4, 8.56 mM NaCl, 18.7 mM NH4Cl, 2 mM MgSO4, 100 μM CaCl2, and 22.2 
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mM D-glucose.  For [U-15N]-TsaC [15N]-ammonium chloride was substituted for 
NH4Cl.  For [U-15N, U-13C]-TsaC D-[U-13C]-glucose and [15N]-ammonium chloride 
were substituted for D-glucose and NH4Cl respectively.
After a one hour recovery period at 37 °C, IPTG was added to a final 
concentration of 1.0 mM, and cultures were grown for an additional four hours 
and harvested, purified, and FactorXa treated as previously mentioned.  The 
proteins were then dialyzed as previously described against 4 L of 100 mM 
sodium phosphate (pH 6.8), 100 mM sodium chloride and snap frozen by placing
them in dry ice until completely frozen.
Protein Gel Filtration
Size exclusion chromatography was performed using a Biosep SEC-
S3000 column (300 x 7.8 mm, 5μM).  The mobile phase was 100 mM sodium 
phosphate (pH 6.8), 300 mM potassium chloride and had a flow rate of 1 mL/min 
over 30 minutes.  Proteins were suspended at a concentration of 2 mg/mL each 
in mobile phase before analysis.  TsaD, TsaE, TsaB, and TsaC were first run 
individually.  When more then one protein was analyzed samples were allowed to
equilibrate at room temperature for 30 minutes before analysis.  Samples were 
then compared to Sigma-Aldrich molecular weight standards to determine 
approximate apparent mass.
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3.0 Results
3.1 Discovery of the t6A Biosynthetic Pathway
The proposed chemistry of t6A formation (Figure 13) suggested that its 
biosynthetic pathway would require multiple enzymatic steps.  Previous work in 
knockout strains of yeast had shown that kae1 (tsaD) and sua5 (tsaC) were 
involved in the biosynthesis of t6A (Figure 11) (51, 52).  To test the hypothesis 
that these genes were sufficient for the formation of t6A in vitro both proteins were
expressed and purified.
The plasmid pBY215.1 containing the E. coli yrdC (tsaC) gene with an N-
terminal 6x histidine tag was transformed into the E. coli cell line BL21(DE3) for 
overexpression.  Overexpression was robust with yields of ~60 mg per L of LB or 
~25 mg per L of M9 minimal media (Figure 14) after affinity purification.
The plasmid pBY216.1 containing the E. coli ygjD (tsaD) gene with an N-
terminal 6x histidine tag was transformed into the E. coli cell line BL21(DE3) for 
overexpression.  Initial attempts of overexpression resulted in high levels of 
expression, however, the recombinant protein was insoluble.  Altering the 
expression conditions, such as including ZnCl2 and lowering the induction 
temperature, proved insufficient to improve the solubility of TsaD.  Therefore, the 
tsaD gene was recloned into the pSUMO vector.  The pSUMO vector includes an
N-terminal SUMO tag which has been shown to improve the stability and 
solubility of numerous proteins (63).  The tsaD gene was cloned from the 
pBY216.1 plasmid using PCR before ligation into the pSUMO vector.  The 
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resulting plasmid, pCDI74, provided robust production of a soluble N-terminal 
SUMO-TsaD recombinant protein.  Overexpression of SUMO-TsaD in E. coli 
BL21(DE3) and subsequent purification using Ni-NTA agarose typically resulted 
in yields of ~20 mg per L of LB.
Initial affinity purification of the SUMO-TsaD fusion construct utilizing Ni-
NTA agarose and a stepwise elution using imidazole resulted in an impure 
protein product which was further purified to homogeneity via ion exchange 
chromatography (Figure 15).
Subsequent cleavage of the N-terminal SUMO tag by the protease ULP 
resulted in an unstable protein which precipitated from solution.  Therefore, the 
N-terminal SUMO tag was retained for all subsequent experiments.
Cloning and Purification of TsaB and TsaE
In vitro assays using the TsaC and TsaD proteins were insufficient to 
reconstitute the t6A pathway in vitro, suggesting that additional proteins were 
required for its biosynthesis in bacteria.
Two additional candidates implicated in the involvement of bacterial t6A 
synthesis were the highly conserved bacterial proteins YeaZ (TsaB) and YjeE 
(TsaE).  Bioinformatic analysis revealed that there was strong physical clustering 
of the tsaB, tsaD, and tsaE genes in bacteria, suggesting the potential for 
involvement in the t6A pathway (Figure 16) (52).  Furthermore, a protein 
interaction network between the TsaD/TsaB and TsaE/TsaB proteins (69) was 
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discovered using a bacterial two-hybrid model.  Finally, complementation of the 
lethal E. coli ygjD (tsaD) knockout with the B. subtilis homolog (ydiE) also 
required the B. subtilis yeaZ homolog ydiC gene to permit growth (52).  
The tsaB and tsaE genes were cloned from E. coli genomic DNA using 
PCR and were inserted into pET32Xa/LIC vector as N-terminal 6x histidine fusion
proteins.  Overexpression in E. coli BL21(DE3) was robust for both recombinant 
proteins.  After purification using Ni-NTA agarose both TsaB (Figure 17) and TsaE
(Figure 18) were typically obtained in yields of ~60 mg per L of LB.  Cleavage 
with FactorXa proceeded with high specificity and efficiency typically resulting in 
over 90% cleavage.
Production of tRNA Templates, RNA Transcriptions and Purification
Klenow reactions to extend synthesized oligonucleotides to full length 
tRNA substrates for E. coli tRNALys(UUU), tRNAIle(CAU), tRNAIle(GAU), and M. 
thermoautotrophicus tRNAGln(CUG) typically resulted in high yields of conversion 
to full length template.  Isolation of the plasmid containing E. coli tRNAThr(GGU) 
and subsequent MvaI digestion and agarose purification, as described in 
experimental, led to yields of approximately 45 nmol of template.  T7 polymerase 
purification produced approximately 50 mg of T7 Polymerase per L of LB.  
Transcription typically yielded 150-300 μg of purified tRNA per mL (Figure 19). 
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In vitro t6A Formation
In order to ascertain if TsaC, TsaD, TsaB and TsaE were sufficient and 
necessary for t6A formation in vitro tRNA precipitation assays were performed.  
These assays were designed to measure the incorporation of either [U-14C]-L-
threonine or [14C]-bicarbonate into tRNA, as previous work indicated their 
involvement in its biosynthesis (45-50).  From these assays it was determined 
that in the presence of TsaC, TsaD, TsaB, and TsaD, radioactive threonine or 
bicarbonate were incorporated into tRNA, consistent with the formation of t6A37-
tRNA.  In the absence of any one of the four proteins no detectable incorporation 
of radioactive threonine or bicarbonate was observed (Figure 20).
To determine the tRNA requirements of t6A formation, a series of tRNAs 
were examined by precipitation assay.  Specifically, in vitro transcribed E. coli 
tRNALys(UUU), E. coli tRNAThr(GGU), M. thermoautotrophicus tRNAGln(CUG), the 
anticodon stem loop from H. sapiens tRNALys -3(UUU) (with a U27-A43 replacement
of G27-C43), and in vivo produced tRNA isolated from S. cerevisiae were 
examined as substrates.  The tRNA isolated from S. cervisiae was isolated from 
either the wild type (WT) strain or a strain deficient in t6A nucleoside (Δsua5) (51, 
52).  
Assays containing full length tRNA with an ANN decoding anticodon (in 
vitro transcribed E. coli tRNAThr(GGU) and E. coli tRNALys(UUU) or Δsua5 tRNA) 
showed robust incorporation of both [U-14C]-L-threonine or [14C]-bicarbonate into 
the tRNA.  In contrast, assays containing the ASL from H. sapien tRNALys-
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3(UUU), fully modified tRNA from wild type S. cerevisiae (already containing the 
t6A modification), or the non ANN decoding in vitro transcribed M. 
thermoautotrophicus tRNAGln(CUG) did not show detectable incorporation of 
radioisotope (Figure 21).
To confirm the in vitro production of t6A, LC-MS was employed to analyze 
the reaction products.  The E. coli tRNALys(UUU) transcript was reacted with 
unlabeled substrate in the presence of the TsaD, TsaB, TsaC and TsaE proteins, 
and the tRNA was subsequently digested and dephosphorylated to 
mononucleosides for analysis by LC or LC-MS.  Comparison of tRNA digestion of
a control showed a new peak in the LC trace which was consistent with authentic
t6A (Figure 22A).  Subsequent LC-MS analysis (Figure 22B) of this peak showed 
compounds with m/z values of 413.14 (t6A) and 281.05 (protonated t6A base) 
thus confirming the radiochemical assays were measuring the formation of t6A .
3.2 Mechanistic Investigation of the t6A Biosynthetic Pathway
t6A ATP Co-product Analysis
To determine which product(s) were formed during ATP activation of 
intermediates (Figure 13) a TLC based assay using α-[32P]-ATP was employed.  
Both AMP and ADP were found as co-products from the activation of 
intermediates leading to t6A (Figure 23).  The AMP co-product was dependent 
upon the presence of both TsaC and threonine (Figure 23a lanes 6, 17-19).  
There is a significant reduction in the production of ADP in the absence of any 
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one of the remaining 3 proteins (Figure 23a lanes 3-16), however, ADP 
production is still observed.  Notably, the production of AMP and ADP is 
independent of tRNA (Figure 23) suggesting the formation of any activated 
intermediates occur independently of tRNA.  An unidentified ATP co-product was 
also found in the presence of TsaC and threonine (Figure 23b, lanes 11, 15, 17-
19).  LC analysis demonstrated this intermediate to be an adenosine derivative 
and the structure of this intermediate was reported to be threonylcarbamoyl 
adenosine monophosphate (TC-AMP) in B. subtilis by Lauhon (71).
LC-MS of Threonylcarbamoyl Adenosine Monophosphate (TC-AMP)
To confirm the production of TC-AMP by E. coli TsaC activity assays were 
carried out with analysis by HPLC.  LC traces of reaction mixtures containing 
ATP, L-threonine and TsaC showed the formation of a new peak (Figure 24b, and
LC-MS analysis confirmed that intermediate was TC-AMP (Figure 24).
Analysis of Carbonate Requirements in TsaC
TC-AMP formation catalyzed by TsaC was shown to require L-threonine 
and ATP.  However, the identity of the carbonate source for this reaction had not 
been definitively shown.  Only TC-AMP and AMP were found as co-products from
the TsaC reaction (Figure 23) and non stoichiometric equivalents of AMP and TC-
AMP are produced (Figure 25).  This suggested that the AMP observed in the 
TsaC assays was the result of TC-AMP degradation to AMP, threonine, and 
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carbonate.  These observations led to two plausible mechanisms of TC-AMP 
formation.  The first (Figure 26) proceeds through a 3 step pathway begining with
ATP and bicarbonate to produce carboxyphosphate and ADP.  Subsequently, 
carboxyphosphate reacts with L-threonine to produce N-carboxy-L-threonine and
phosphate.  The N-carboxy-L-threonine subsequently reacts with the ADP 
produced in the first step to produce TC-AMP and a second equivalent of 
phosphate.  The second mechanism proceeds through a 2 step pathway (Figure 
27), in which TsaC catalyzes the formation of a N-carboxy-L-threonine from CO2 
followed by reaction with ATP to produce TC-AMP and pyrophosphate.
To determine if TsaC used CO2 or bicarbonate as the source of the 
carbamoyl moiety in t6A, HPLC analysis of the reverse reaction was carried out.  
Purified TC-AMP was reacted with either phosphate or pyrophosphate and the 
extent of conversion by TsaC to ATP was monitored (Figure 28).  TsaC catalyzed 
formation of ATP in the presence of phosphate would suggest the formation of 
TC-AMP occurring through a 2 step activation pathway using bicarbonate (Figure
26), while TsaC catalyzed formation of ATP by pyrophosphate would indicate a 1 
step activation using CO2 (Figure 27).
ATP formation was observed under both conditions, although the reaction 
appears more robust in the presence of pyrophosphate.  In order to exclude the 
possibility ATP formation was due to contaminating phosphate or pyrophosphate 
in one of the reactions, the reactions were investigated with [32P]-PPi and [32P]-Pi 
followed by TLC analysis (Figure 29).  [32P]-Pi was generated by the treatment of 
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[32P]-PPi with alkaline phosphatase.  
While the problem of contaminating species is apparent from Figure 29, 
the level of ATP produced in the PPi reaction is substantially higher (Figure 29, 
Lanes 3, 6) than that in the Pi reaction.  The low level of ATP formation observed 
in the Pi reaction is likely due to a low level of contaminating PPi (Figure 29, 
Lane 7).  As such, it appears the canonical substrate for TsaC is CO2.
Analysis of ATP Co-products Derived from TsaB, TsaE, and TsaD
Analysis of the archaeal t6A biosynthetic pathway suggested that the 
protein Bud32 (a t6A protein found in eukaroytes and archaea) was functioning as
a P-loop ATPase, and that this activity was required for the formation of t6A in 
vitro (72).  To determine if the ATP to ADP conversion by TsaB, TsaE, and TsaD 
was the result of an essential ATPase activity, the formation of t6A from TC-AMP 
as catalyzed by TsaC, TsaD, TsaE and TsaB was investigated in the presence 
and absence of ATP.
Radiochemical tRNA precipitation assays using [U-14C]-TC-AMP indicated 
that the transfer of the carbamoylthreonine moiety from TC-AMP to produce t6A 
occurs in the presence of TsaD, TsaB, and TsaE and that ATP and TsaC are not 
required for this transfer (Figure 30).
To investigate whether the ADP formation by TsaD, TsaB, or TsaE was a 
result of protein phosphorylation a bioinformatic analysis of the proteins for 
possible phosphorylation sites was performed using NetPhosBac, which 
45
indicated that all four proteins have potential phosphorylation sites (Table 6).  To 
biochemically address this issue TsaD, TsaB, TsaE, and TsaC were incubated 
together or pairwise, in the presence or absence of tRNA, with γ-[32P]-ATP.   The 
proteins were then analyzed for 32P incorporation from ATP after isolation from 
the reaction mixture using affinity tag binding or by phosphorimaging after SDS-
PAGE, and nitrocellulose transfer.  No incorporation of 32P into protein was 
observed in any sample tested.
Enzyme Optimization and Kinetics
The pH optimum of t6A formation was assessed by tRNA precipitation 
assays.  t6A Formation was observed throughout the tested pH range (Figure 31).
The rate of t6A formation drops off significantly after a pH of 8.  The pH optimum 
of the reaction was determined to be approximately pH 7.5.
Steady state kinetics of TsaC catalyzed formation of TC-AMP were initially 
investigated by HPLC analysis of TsaC reaction products (Figure 32, 33).  Kinetic
parameters were determined for ATP and L-threonine substrates.  Subsequent 
analyses were performed through the use of a coupled enzyme assay as 
described below.
In order to rapidly determine the rate of the TsaC catalyzed reaction a 
coupled enzyme system was developed.  The coupled assay proceeded through 
the following enzymatic conversions:
1. ATP + CO2 (aq) + amino acid is converted by TsaC to a carbamoyl 
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adenosine monophosphate derivative and pyrophosphate.
2. Pyrophosphate + D-fructose-6-phosphate is converted by a 
pyrophosphate dependent phosphofructokinase to D-fructose-1,6-
diphosphate + phosphate.
3. D-Fructose-1,6-diphosphate is converted to dihydroxyacetone phosphate 
+ D-glyceraldehyde-3-phosphate by aldolase.
4. D-glyceraldehyde-3-phosphate is converted to dihydroxyacetone 
phosphate by triosephosphate isomerase.
5. 2 dihydroxyacetone phosphates + 2 β-nicotinamide adenine dinucleotide 
(reduced, NADH) are converted to 2 glycerol-3-phosphate + 2 β-
nicotinamide adenine dinucleotide (oxidized, NAD+) by glycerophosphate 
dehydrogenase.
The extent of the reaction was measured from the conversion of NADH to 
NAD+ by monitoring UV absorbance at 340 nm.  Assays were initially run to 
ensure that the observed rate of NADH oxidation correlated with the TsaC 
reaction, not the coupled assay rate.  Subsequent work by others in the lab 
revealed an apparent Vmax/Km of 1.6 -min for the coupled assay, which was 
greater than that determined for TsaC, confirming that TsaC was not the rate 
limiting step.  Furthermore, this work demonstrated that the coupled assay was 
not inhibited by ATP concentrations below 3 mM.  For a UV-VIS trace showing 
maximum coupled assay rate, background oxidation rate of NADH, and the TsaC
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reaction see Figure 34. 
Kinetic parameters were elucidated for ATP (Figure 35), L-threonine 
(Figure 36), L-serine (Figure 37), and D,L-hydroxynorvaline (Figure 38), and are 
summarized in Table 7.  Relative activity using glycine was determined to be 
1.95% while the amino acids  L-alanine and L-valine did not serve as substrates.
Analysis of TsaC Mutants
In order to determine the solution structure of TsaC, isotope labeled 
protein was produced ([U-15N, U-13C]-TsaC and [U-15N]-TsaC) and analyzed by 
NMR.  The resulting solution structure (Figure 39) provided insights on the amino
acids involved in substrate binding (73).  Specifically, saturation transfer 
difference NMR had implicated the residues K53, R110, and N141 in ATP binding
and the residues K50 and R52 in phosphate coordination (73).  Additionally, gene
complementation studies with TsaC mutants implicated R52 as critical for t6A 
formation in vivo (51).  All of the residues are found in close proximity to bound 
TC-AMP in a crystal structure of Sulfolobus tokadaii Sua5 (TsaC) (Figure 40) 
(74).
To confirm that these residues were important to catalysis by TsaC, a 
preliminary analysis of the TsaC mutants K53A, R110A, K50A, N141A, and R52A
was carried out by measuring their relative activities using HPLC to monitor TC-
AMP formation.   The results are summarized in Table 8.
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3.3 Structural Investigation of the Proteins Involved in t6A Biosynthesis
Protein Interactions (SDS-PAGE)
To determine if the TsaD, TsaB, TsaC, and TsaE proteins were capable of 
binding to each other in vitro protein pull down experiments were carried out 
(Figure 41).  Protein pairs (one with an affinity tag, one without) were incubated 
followed by Ni-NTA chromatography and SDS-PAGE analysis.  These 
experiments indicated TsaD interacts with both TsaC and TsaB, TsaC interacts 
with TsaB, and TsaE interacts with TsaB, consistent with the formation of a single 
protein complex.
Protein Gel Filtration Chromatography
Size exclusion chromatography was performed in order to investigate the 
quaternary structure of the proteins involved in t6A biosynthesis.  A Sigma Aldrich 
size exclusion standard was used to create a standard curve (Figure 42).  
Apparent molecular masses of the individual proteins are reported in Figure 43.  
These results are consistent with TsaB being dimeric and TsaC being monomeric.
TsaE primarily runs with an apparent molecular mass between a dimer and trimer
with some monomer being observed.  TsaD primarily runs as a monomer with an 
additional peak observed corresponding to a trimer.
Definitive determination of subunit arrangement of multiple enzyme 
combinations was difficult to determine.  This was due to the similar sizes of 
TsaC, TsaB and TsaE, the tendency of these proteins to form dimers with 
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themselves and/or each other, and TsaD having extremely broad elution peaks.  
The formation of a peak consistent with a TsaD + TsaB heterodimer is illustrated 
by an overlay of TsaD, TsaB, and TsaD + TsaB chromatograms shown in Figure 
44.  It is important to note that TsaD was analyzed as a fusion protein (SUMO-
TsaD) which likely interfered in this analysis.  A summary of determined apparent 
weights for all the protein complexes is reported in Table 9.
3.4 Peripheral Analysis of the t6A Biosynthetic Pathway
Analysis of s6A, hn6A and g6A
Analysis of reactions using non-threonine amino acids suggested that 
TsaC is promiscuous in its production of carbamoyladenosine derivatives.  
Specifically, LC analysis indicated TsaC is able to catalyze the formation of a 
product with a similar retention time to TC-AMP in the presence of 
hydroxynorvaline (Figure 45), serine (Figure 46), and glycine (Figure 47).  In 
contrast, no product was observed via HPLC when L-alanine or L-valine were 
included in the assay.  To confirm the formation of hydroxynorvalyl (HNC-AMP), 
serinyl (SC-AMP), and glycinyl (GC-AMP) carbamoyl adenosine 
monophosphates the relevant assays were analyzed by LC-MS (Figures 48-50).  
In the presence of D,L-hydroxynorvaline a m/z ion of 505.108 was found.  
This corresponds to the predicted mass of 505.11 for HNC-AMP with an error of 
3.86 ppm.  In the presence of L-serine a m/z ion of 477.080 was found.  This 
corresponds to the predicted mass of 477.08 for SC-AMP with an error of 0.16 
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ppm.   In the presence of glycine a m/z ion of 447.067 was found.  This 
corresponds to the predicted mass of 447.07 GC-AMP with an error of 5.79 ppm.
In order to determine if carbamoyl adenosine derivatives other then TC-
AMP could be incorporated into tRNA using the t6A biosynthetic machinery tRNA 
precipitation assays were performed (Figure 51).  Within the limits of detection of 
the assay (1.4% relative activity of L-threonine), none of the non-threonine 
carbamoyl adenosine derivatives are incorporated into tRNA.
Carboxythreonylation of Proteins, Cloning and Purification of PrmC
TC-AMP has a stability on the lower end of biologically relevant 
phosphoric anhydrides (71, 75).  This instability in water suggests the potential to
react with other nucleophiles, which led us to investigate if TC-AMP was capable 
of reacting with proteins and DNA.  In particular, the methyl transferase PrmC is 
often found clustered with the t6A proteins (76) and is also involved in translation, 
leading to the hypothesis that carboxythreonylation of PrmC by TC-AMP might 
serve as a regulating mechanism.
To test this hypothesis the prmC gene was cloned from E. coli genomic 
DNA and was inserted into pET32Xa/LIC vector as a N-terminal 6x histidine 
fusion protein.  Overexpression in E. coli BL21(DE3) was robust.  After 
purification using Ni-NTA agarose (Figure 52) PrmC was typically obtained in 
yields of ~30 mg per L of LB.
Carboxythreonylation of proteins was assessed by by the generation of [U-
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14C]-TC-AMP in the presence of various proteins.  After incubation in the 
presence of [U-14C]-TC-AMP SDS-PAGE and nitrocellulose transfer were 
performed and radioactive incorporation into proteins was assessed via 
phosphorimaging.  Carboxythreonylation of proteins was examined for the 
following combination of proteins: TsaC alone, TsaC with PrmC, TsaC with TsaD, 
TsaB and TsaE.  In all tested protein combinations there were no observable 
incorporation of radioisotope.
Carboxythreonylation of DNA
The non-enzymatic carboxythreonylation of DNA by TC-AMP was 
examined to determine if its build up in the cell resulted in DNA modification.   
This was accomplished by the generation of [U-14C]-TC-AMP in the presence of 
either genomic DNA or tRNALys(UUU) template DNA.  Examination of excised 
agarose gel fragments by scintillation counting indicated that neither genomic 
DNA or small dsDNA was capable of being non-enzymatically 
carboxythreonylated.  Subsequent DNA precipitation assays supported this result
with no activity observed above background.
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4.0 Discussion
4.1 Elucidation of the t6A Biosynthetic Pathway
The first clues to the identity of the enzyme(s) involved in t6A biosynthesis 
were revealed when comparative genomic and genetic studies (51, 52, 77) linked
the Sua5 (TsaC) and Kae1 (TsaD) protein families to its synthesis.  Notably, 
these protein families were ranked among the top ten protein families of unknown
function requiring characterization (61).  Specifically, the knockout of the yeast 
genes sua5 and kae1 (homologous genes to E. coli yrdC (tsaC) and ygjD (tsaD)) 
led to the loss of t6A in vivo (Figure 11).  
Despite direct evidence of the involvement of the TsaC and TsaD proteins 
in t6A biosynthesis, they proved insufficient to reconstitute t6A biosynthesis in 
vitro, suggesting the involvement of additional proteins (52, 77).  Three 
observations narrowed the search for these additional proteins;  YgjD (TsaD) 
forms an interaction network with the YeaZ (TsaB) and YjeE (TsaE) proteins (69), 
complementation of the lethal E. coli ygjD (tsaD) knockout with the B. subtilis  
homolog (ydiE) also requires the B. subtilis yeaZ homolog ydiC gene to permit 
growth (52), and there is strong bacterial clustering between ygjD (tsaD), yjeE 
(tsaE) and yeaZ (tsaB)  (Figure 16).  These observations led to investigation of 
ygjD and yeaZ genes in bacterial t6A biosynthesis.  
Generation of expression constructs of the tsaB, tsaC, tsaD, and tsaE 
genes and the subsequent purification of their gene products from E. coli, 
allowed probing of their involvement in t6A biosynthesis.  Radiochemical 
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incorporation of [14C]-bicarbonate and [U-14C]-L-threonine into tRNA in the 
presence of TsaD, TsaB, TsaC, and TsaE (Figure 20) demonstrated the first 
reconstitution of its pathway in vitro.  Significantly, these experiments showed 
that t6A formation was dependent upon all four proteins in bacteria.  Notably, 
YeaZ and YjeE are not found in eukaroytes, suggesting that bacterial t6A 
biosynthesis is a potential target for antibiotic development.
4.2 Mechanistic Studies of the t6A Biosynthetic Pathway
RNA Requirements of t6A Formation
Analysis of the tRNA substrate requirements of t6A formation (Figure 21) 
demonstrated that modification of tRNA was not a requirement for its formation in
vitro.  The failure of an anticodon stem loop (H. sapiens tRNALys-3(UUU)) to serve
as a substrate, despite evidence that TsaC binds the unmodified ASL with high 
affinity and specificity (78), suggested that full length tRNA was required for the 
formation of t6A.  This observation was consistent with previous studies in 
Xenopus laevis oocytes that suggested the L-shaped tRNA architecture was 
required for t6A modification (79).  Furthermore, non ANN decoding tRNA also 
failed as substrates, consistent with previous studies demonstrating that t6A 
formation is specific to ANN decoding tRNA (79).  Analysis of tRNAPhe(GAA) has 
provided some insight to the specificity of this reaction (71).  Specifically, native 
tRNAPhe(GAA) does not serve as a substrate for t6A formation while the tRNAPhe 
A36 to U36 mutant does.  These results suggest that the tRNA requirements for t6A
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formation are a U36, A37, and the L-shaped architechure of full length tRNA.
Identity of Activated Intermediates in t6A Production
Canonical carbamoyl transfer reactions proceed through a two step 
activation pathway (Figures 10, 53) (62, 80, 81).  Typically, the first step is the 
activation of bicarbonate to either carboxyphosphate or carboxyadenylate.  
Subsequently, this activated carbonate is reacted with an amine to form a 
carbamoyl group with the loss of the first activating group.  The carbamoyl group 
is then activated to either a carbamoyladenylate or carbamoylphosphate before 
subsequent transfer.  In the context of t6A biosynthesis, one would expect 2 
equivalents of ATP to satisfy its energy requirements for carbamoyl transfer.  The 
first of these intermediates would likely be either a carboxyadenylate or 
carboxyphosphate which could subsequently react with either the N6 of A37 or the 
α-amine of threonine.  After the carbamoyl linkage has formed, a second 
activation step would be required to form an acyl-phosphate or adenylate to react
with the remaining component to produce t6A (Figure 13).  
Analysis of ATP co-products produced in the t6A reaction suggested both 
AMP and ADP were produced (Figure 23) consistent with the formation of at least
two activated intermediates in t6A synthesis.  The ADP co-product is produced as 
a co-product by TsaD, TsaB, and TsaE and is enhanced by the inclusion of all 
three proteins (Figure 23b lanes 4, 12-14).  The AMP co-product is dependent 
upon the presence of both TsaC and threonine (Figure 23a lanes 6, 17-19).  
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Notably, the production of AMP and ADP is independent of tRNA (Figure 23) 
suggesting that a non tRNA dependent intermediate is formed.
The first intermediate identified in the t6A pathway was TC-AMP (71) which
is produced by TsaC utilizing ATP and L-threonine.  TC-AMP is already activated 
for carbamoyl transfer, suggesting no additional activation is required by the 
other t6A proteins.  The generation of a carboxyadenylate by TsaC was excluded 
by HPLC analysis as only one equivalent of ATP is used in the production of TC-
AMP (Figure 25).  This suggested that TsaC was either proceeding through a 
carboxyphosphate intermediate (Figure 26) or using CO2 as a substrate (Figure 
27).
Subsequent investigation (Figure 29) demonstrated the production of 
pyrophosphate in the generation of TC-AMP consistent with CO2 as the 
carbonate source for t6A formation.  This was consistent with the previously 
reported proposal of a N-carboxy-L-threonine intermediate being formed in the 
active site of TsaC (71).  This intermediate would likely be formed by the localized
concentration of CO2 and L-threonine in the active site of TsaC as CO2 is 
significantly more electrophillic then bicarbonate and aliphatic amines have been 
shown to form stable carbamoyl moieties in the presence of high concentrations 
of CO2 under alkaline conditions (82).  As such, the function of TsaC in TC-AMP 
production is likely two fold, increase the localized concentration of reactants and
to catalyze acid base catalysis to facilitate the reaction of L-threonine with CO2.
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Analysis of ADP Formation by TsaD, TsaB, and TsaE
Recent investigations (72) suggested that the archaeal protein Bud32 (a 
protein involved in t6A biosynthesis in archaea and eukaryotes) was acting as a 
P-loop ATPase and ADP production was required for t6A formation.  However, 
experiments in which [U-14C]-TC-AMP was used as a precursor to t6A formation 
(Figure 30) excluded the possibility that TsaD, TsaB or TsaE were functioning as 
an essential ATPase in E. coli, as the transfer of the carbamoylthreonine of [U-
14C]-TC-AMP to tRNA to produce t6A occurred readily in the absence of ATP.  
Furthermore, analysis of TsaE mutants deficient in ATPase activity are still 
capable of forming t6A, suggesting that the formation of ADP is not required for 
t6A formation (84), consistent with our observations that TC-AMP is sufficient for 
t6A formation in the absence of ATP.  As such, ADP formation linked to TsaB, 
TsaD, and TsaE is likely not directly related to the chemistry of t6A formation.
Structural investigations have implicated TsaE's ATPase activity in the 
formation of a stable TsaB-TsaD-TsaE heterotrimer (84).  This hypothesis is 
supported by the increased ATP hydrolysis in the presence of these three 
proteins (Figure 23).  As such, the ATPase activity of TsaD, TsaB, and TsaE could
be responsible for the maintenance of a carbamoyl acceptor complex but this has
yet to be definitively shown.  The current understanding of the biochemical 
mechanism of t6A formation determined from this work is summarized in Figure 
54.
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4.3 Peripheral Analysis of the t6A Biosynthetic Pathway
Substrate Analysis of the TsaC Reaction
Previous experiments revealed that tRNAs can contain a variety of 
adenosine N6 modifications in addition to t6A.  Specifically, N6-
hydroxynorvalylcarbamoyl adenosine (hn6A) (85) and N6-glycinylcarbamoyl 
adenosine (g6A) (86).  These modifications differ only in the identity of the amino 
acid appended to the nucleoside (Figure 12).  Given the similarity of these 
modifications to t6A it was hypothesized that the t6A biosynthetic pathway may be 
promiscuous in its incorporation of amino acids.  
Analysis of a series of amino acids similar to threonine indicated two that 
were efficiently converted to their XC-AMP equivalents, hydroxynorvaline (Figure 
45) and serine (Figure 46).  Additionally, low levels of glycine conversion were 
observed (Figure 47).  Kinetic analysis of TsaC catalyzed XC-AMP formation 
demonstrated that the production of HNC-AMP and SC-AMP occurs at 
comparable efficiency to the formation of TC-AMP (Table 7) suggesting that the 
formation of these XC-AMP derivatives can occur in vivo.
Subsequent analysis of HNC-AMP and SC-AMP demonstrated that they 
were not incorporated into tRNA and that the TsaD, TsaB, and TsaE proteins 
provide the selectivity to ensure only t6A is produced through this pathway in E. 
coli.  As g6A was found in yeast and hn6A in thermophillic bacteria and archaea it 
is important to note that the proteins involved in t6A formation in these organisms 
may be less selective in their incorporation of XC-AMP derivatives.
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Carboxythreonylation of DNA and Proteins
TC-AMP is a reactive compound that rapidly hydrolyzes to AMP, L-
threonine, CO2 and can rearrange to trans-(4S,5R)-5-Methyl-2-oxazoldinone-4 
carboyxlic acid (L-Thr-ox) (71).  Its stability is on the lower end of biologically 
relevant phosphoric anhydrides (approximately 1/3 the stability of 
carbamoylphosphate) due to multiple intramolecular degradation pathways and 
the higher free energy of hydroloysis of adenylates (71, 75, 87, 88).  Given this 
reactivity it is possible that nucleophiles other than water might react with TC-
AMP such as proteins and DNA.
A protein of particular interest for investigation of carboxythreonylation was
PrmC.  PrmC is a protein-(glutamine-N5) methyltransferase which has been 
shown to have activity for release factors RF1 and RF2, proteins involved in 
translation (89, 90).  This protein is is often clustered with the TsaC protein and is
found fused to TsaC in Mycoplasma mobile.  It was hypothesized that enzymatic 
or non-enzymatic carboxythreonylation of PrmC could regulate its 
methyltransferase activity.  This would be significant as both TsaC and PrmC are 
involved in translation.  In a situation where excess TC-AMP was being produced
by TsaC, PrmC could be carboxythreonylated to regulate its activity.  However, 
experiments demonstrated that neither DNA, PrmC, or any of the t6A related 
proteins were non-enzymatically carboxythreonylated in the presence of excess 
TC-AMP.
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4.4 Structural Investigation of t6A Pathway
The instability of TC-AMP, coupled with involvement of the KEOPS 
complex in archaea and eukaroytes, and previous examples of the channeling of 
activated carbamoyls (91, 92), suggested that the proteins involved in t6A 
synthesis might utilize substrate channeling through the formation of a protein 
complex.  Protein pulldown experiments demonstrated that the TsaD, TsaC, 
TsaB, and TsaE proteins interacted with one or more protein partners in vitro, 
consistent with the formation of a single protein complex (Figure 41), supporting 
this hypothesis.  Complementary gel filtration analysis of the E. coli proteins 
demonstrated the formation of a protein complex between TsaD and TsaB (Figure
44) consistent with a TsaD-TsaBx2 complex or a TsaD-TsaB complex with a non-
idealized protein shape, which have been shown to effect the apparent molecular
mass of proteins in gel filtration experiments (93-96).
No direct evidence of the hypothetical TsaD, TsaB, TsaC, and TsaE protein
complex has been shown but the evidence supporting such a complex continues 
to grow.  In eukaroytes t6A formation is catalyzed by the proteins Kae1 (TsaD), 
Sua5 (TsaC), Bud32 and Cgi121 (44).  Crystal structures of both the eukaroytic 
Kae1-Bud32-Cgi121 heterotrimer (97) and bacterial TsaDx2-TsaBx2 
heterotetramer have been solved (Figures 55, 56) (84).  Furthermore, gel 
filtration utilizing the the TsaD, TsaB, and TsaE proteins from Thermotoga 
maritima have demonstrated the formation of an α2β2γ2 complex (98).  Given the 
unstable nature of the TC-AMP intermediate it is likely that TsaC binds the 
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already formed TsaE-TsaB-TsaD heterohexamer and channels TC-AMP to the 
active site of TsaD.
4.5 The Essentiality of t6A, Emerging Differences in Eukaroytic and 
Bacterial Systems
Bioinformatic analysis of the t6A biosynthetic pathway has shown that 
there are substantial differences in t6A formation between eukaryotes and 
prokaryotes.  In both systems the TsaC and TsaD proteins are conserved.  
Bioinformatic and biochemical investigations have demonstrated that the TsaC 
protein is a threonylcarbamoyl adenosine monophosphate synthase and TsaD is 
a N6-threonylcarbamoyl adenosine synthase.  In prokaroytes, two additional 
proteins are required for the synthesis of t6A, TsaB and TsaE.  In archaea and 
eukaryotes there are several different protein complexes which can synthesize 
t6A.  In most eukaroytes the proteins TsaC, TsaD, Cgi121, Pcc1, and and Bud32 
are required (99).  In yeast, an additional protein, Gon7 is also required.  The 
mitochondrial protein Qri7 requires only TsaC to produce t6A (44).  
Beyond the differences in the protein architecture required for t6A 
formation there is also a difference in the essentiality of t6A.  In most prokaryotes 
t6A is essential.  In numerous eukaroytes it is dispensable but its loss leads to 
severe growth defects.  Recently, an important difference between eukaryotic 
and bacterial isoleucyl-tRNA synthetases was found (44).  Specifically, two 
isoforms of tRNAIle (CAU and GAU), with or without t6A, were examined as 
61
substrates for isoleucyl-tRNA synthetases from both eukaryotes and bacteria.  In 
bacteria, t6A37-tRNAIle(CAU) and t6A37-tRNAIle(GAU) are positive determinants for 
aminoacylation by isoleucyl-tRNA synthetase while in eukaroytes they are not.  
This result is consistent with differences in eukaryotic and prokaryotic 
translational machinery as a result of t6A modification of tRNA and may explain 
the essentiality of t6A in bacteria.  The major architectural differences between 
the t6A biosynthetic machinery in the different domains of life, and the strictly 
required nature of the t6A modification in prokaryotes suggests that this system 
has a potential as a future antibiotic target.
4.6 Future Work
Despite significant advancements in the understanding of t6A biogenesis 
numerous questions remained unresolved.  One such question is if TsaC 
homologs in other organisms are also promiscuous and how this promiscuity is 
dealt with.  In the case of E. coli, the TsaD, TsaB, and TsaE proteins have been 
demonstrated to have high selectivity for TC-AMP over other XC-AMP 
derivatives.  Due to the discovery of g6A in yeast and hn6A in archaea and 
thermophilic bacteria, it is necessary to show the selectivity of their t6A machinery
for XC-AMPs.  Specifically, examination of eukaryotic and archaeal t6A machinery
could lead to the formation of g6A and hn6A in vitro.
Additional investigation of the ATPase activity of TsaB and TsaE is also 
required.  Despite the demonstration that the ATPase activity of these proteins is 
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not required for the formation of t6A it is unknown if this activity effects its rate of 
formation.  This could be addressed through monitoring the rate of t6A formation 
from TC-AMP in the presence or absence of ATP.  Similarly, this could be 
addressed through kinetic analysis of t6A formation utilizing TsaE and/or TsaB 
mutants deficient in ATPase activity.
To determine the TsaC residues involved in the formation of TC-AMP 
additional investigation would be required.  This could be accomplished through 
additional characterization of the mutants investigated in this work.  Specifically, 
full kinetic characterization of these mutants could provide insight on their relative
binding of TsaC substrates to confirm their suggested roles in the catalysis of TC-
AMP (73).  R52 of TsaC is a residue that merits particular attention.  Previous 
investigation demonstrated the R52A mutant of TsaC was not capable of 
rescuing t6A production in Δsua5 yeast (51).  Furthermore, HPLC analysis 
indicates that the R52A mutant is incapable of producing TC-AMP in vitro.  This 
would suggest that the mutation of R52A is either detrimental to the structure or 
stability of TsaC, or that this residue is directly involved in the catalysis of TC-
AMP.
To access the structural implications of the R52A mutant circular dichroism
could be employed to determine if any major architectural changes are occurring 
due to this mutation.  Furthermore, conservative mutations such as R52K could 
be generated.  If the R52K mutant was capable of rescuing TC-AMP formation it 
would provide further evidence that R52 of TsaC was directly involved in its 
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formation.
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Table 1: Degeneracy in the genetic code
The genetic code showing degeneracy.  Amino acids which have six codons are 
colored pink, four yellow, three blue, two orange, and one green.  Stop codons 
are colored red.
Table 2: Expanded wobble hypothesis 
Initial wobble hypothesis vs expanded wobble hypothesis.  5-methylene uridine 
constitutes all derivatives of m5U excluding 2-thiouridine.  2-thiouridine and 5-
oxyuridine include all derivatives.  tRNA 37 corresponds to the conserved 3' 
adjacent purine.  Abbreviations of nucleosides: t6A (N6-threonylcarbamoyl 
adenosine), m6A (N6-methyladenosine), m1G (1-methylguanosine), and wY 
(wybutosine).  Table reproduced from (21).
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Second Base
First Base U C A G Third Base
U
U U U
Phe
U C U
Ser
U A U
Tyr
U G U
Cys
U
U U C U C C U A C U G C C
U U A
Leu
U C A U A A Stop U G A Stop A
U U G U C G U A G Stop U G G Trp G
C
C U U C C U
Pro
C A U
His
C G U
Arg
U
C U C C C C C A C C G C C
C U A C C A C A A
Gln
C G A A
C U G C C G C A G C G G G
A
A U U
Ile
A C U
Thr
A A U
Asn
A G U
Ser
U
A U C A C C A A C A G C C
A U A A C A A A A
Lys
A G A
Arg
A
A U G Met A C G A A G A G G G
G
G U U
Val
G C U
Ala
G A U
Asp
G G U
Gly
U
G U C G C C G A C G G C C
G U A G C A G A A
Glu
G G A A
G U G G C G G A G G G G G
Wobble Hypothesis Expanded Wobble Hypothesis
tRNA 34 Codon 3 tRNA 34 Codon 3 tRNA 37
G C, U G C, U
C G C G
I U, C, A I U, C, A
U A, G 5-methylene uridine G wY
2-thiouridine A, G
5-oxyuridine A, G, C, U
t6A
m6A
m1G
Table 3: N6-carbamoyladenosine modifications
Examples of modifications in tRNA that differ only slightly in composition from t6A.
Abbreviations used N6-glycinylcarbamoyladenosine (g6A), N6-
threonylcarbamoyladenosine (t6A), 2-methylthio-N6-threonylcarbamoyladenosine 
(ms2t6A), N6-methyl-N6-threonylcarbamoyladenosine (m6t6A), N6-
hydroxynorvalylcarbamoyladenosine (hn6A), 2-methylthio-N6-
hydroxynorvalylcarbamoyladenosine (ms2hn6A).
Table 4: Oligonucleotides used for the cloning of tsaD, tsaB, tsaE, tsaC 
mutants and prmC genes
tsaE, tsaB, tsaC, and prmC denote oligonucleotides that used standard 
FactorXa/LIC cloning.  A single set of oligonucleotides were used to clone the 
tsaC K53A, R110A, K50A, and R52A genes into a FactorXa/LIC vector.  tsaD 
cloning was accomplished as described in (63).   N141A denotes 
oligonucleotides used for QuikChange mutagenesis to generate the tsaC N141A 
mutant.
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Modification
-NA-
Methylthio derivative
Methyl derivative
Threonine is replaced by hydroxynorvaline
Threonine is replaced by hydroxynorvaline and methylthiolated
Threonine is replaced by glycine
Similarity to t6A
t6A
ms2t6A
m6t6A
hn6A
ms2hn6A
g6A
Target Primer Primer Sequence
Sense 5′-GGTATTGAGGGTCGCATGATGAATCGAGTAATTCCG-3′
Antisense 5′-AGAGGAGAGTTAGAGCCTTAACCGGCTAAACGCGCCAG-3′
Sense 5′-GGTATTGAGGGTCGCATGCGAATTCTGGCTATCG-3′
Antisense 5′-AGAGGAGAGTTAGAGCCTCATTCTTTGCCCGGAAG-3
Sense 5'-CCGTATATATATTGGATCCCGTGTACTTGGTATTGA-3'
Antisense 5'-CTAGAAGTACAGTAAGCTTACGCAGCCGGTA-3'
Sense 5'-GGTATTGAGGGTCGCATGGAATATCAACACTGG-3'
Antisense 5'-AGAGGAGAGTTAGAGCCTCATTGATAATAGCGGCCG-3'
Sense 5'-GGTATTGAGGGTCGCAATAATAACCTGCAAAG-3'
Antisense 5'-AGAGGAGAGTTAGAGCCTTACCCCTGTCGAAAC-3'
Sense 5'-GGTTTCTACCAGTGCCGCCTTGAGTGGATTGCC-3'
Antisense 5'-GGCAATCCACTCAAGGCGGCACTGGTAGAAAC-3'
tsaE
tsaE
tsaB
tsaB
tsaD
tsaD
prmC
prmC
tsaC
tsaC
tsaC N141A
tsaC N141A
Table 5: Oligonucleotides used for tRNA templates
All oligonucleotides are oriented 5'-3'.  Oligonucleotide numbers correspond as 
follows: E. coli tRNALys(UUU) sense (1) and antisense (2).  E. coli tRNAIle(CAU) 
sense (3) and antisense (4).  E. coli tRNAIle(GAU) sense (5) and antisense (6).  
M. thermoautotrophicus tRNAGln(CUG) sense (7) and antisense (8).  Human 
tRNALys -3(UUU) sense (9) antisense (10).  E. coli tRNAThr(GGU) sense (11-13) 
and antisense (14-16).  tRNAThr was produced by ligating six oligonucleotide 
pieces together before ligation into pUC18.  
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# Oligonucleotide Sequence
1 AATTCCTGCAGTAATACGACTCACTATAGGGGTCGTTAGCTCAGTTGGTAGAGCAG
2 TGGTGGGTCGTGCAGGATTCGAACCTGCGACCAATTGATTAAAAGTCAACTGCTCTACC
3 AATTCCTGCAGTAATACGACTCACTATAGGGCCCCTTAGCTCAGTGGTTAGAGCAGGCG
4 TGGTGGCCCCTGCTGGACTTGAACCAGCGACCAAGCGATTATGAGTCGCCTGCTCT
5 AATTCCTGCAGTAATACGACTCACTATAAGGCTTGTAGCTCAGGTGGTTAGAGCGC
6 TGGTAGGCCTGAGTGGACTTGAACCACCGACCTCACCCTTATCAGGGGTGCGCTCTAAC
7 TGCAGTAATACGACTCACTATAAGTCCCGTGGGGTAGTGGTAATCCTGC
8 TGGTAGTCCCGAGCGGAGTCGAACCGCTGTCGCCGGGTCCAAAGCCCAGCAGGATTAC
9 TAATACGACTCACTATAGGCAGACTTTTAATCTGC
10 GCAGATTAAAAGTCTGCCTATAGTGAGTCGTATTA
11 AGCTTTAATACGACTCACTATAGGGGCTGATATGGCTCAG
12 TTGGTAGAGCGCACCCTTGGTAGGGGTGGGGTCCCCAGTTCGACTCTGGG
13 TATCAGCACCATATGCTAGTTATTGCTCAGG
14 GATCCCTGAGCAATAACTAGC
15 ATATGGTGCTGATACCCAGAGTCGACTGGGGACCCCACCCCTACCAAGGG
16 TGCCTCTACCAACTGAGCCATATCAGCCCCTATAGTGAGTCGTATTAA
Table 6: Phosphorylation sites of proteins involved in t6A formation
1) Predicted phosphorylation sites of t6A proteins.  2) Scores above 0.5 indicate a
high potential for phosphorylation.  Scores were calculated using the 
NetPhosBac algorithm.
Table 7: Summary of TsaC kinetic parameters
1) Method indicates whether the kinetic parameters were determined from HPLC 
or coupled assay.
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Protein Residue Residue #
TsaD SDGSSEIFF S 35 0.767
TsaD KIKKTTPLR T 44 0.648
TsaD IKKTTPLRR T 45 0.527
TsaD QTGGSRVLG S 125 0.618
TsaD TVGRSLAFA S 221 0.501
TsaD AGGVSANRT S 394 0.605
TsaD SANRTLRAK T 398 0.567
TsaD DLGVSVRPR S 448 0.804
TsaB RGPGSFTGV S 67 0.649
TsaB KNGATRVLA T 109 0.63
TsaB KPLVSTSAN S 263 0.584
TsaB LVSTSANLS S 265 0.632
TsaB RLNPSEIRD S 302 0.547
TsaC ETIFSRWPG S 98 0.501
TsaC KPLVSTSAN S 148 0.584
TsaC LVSTSANLS S 150 0.632
TsaC RLNPSEIRD S 187 0.547
TsaE SAVSSAGEL S 142 0.663
Sequence1 Score2
Substrate
ATP 0.039 +/- 0.003 0.11 +/- 0.04 HPLC
ATP 0.30 +/- 0.01 0.30 +/- 0.04 Coupled Assay
L-threonine 0.063 +/- 0.005 1.4 +/- 0.5 HPLC
L-threonine 0.25 +/- 0.009 0.33 +/- 0.05 Coupled Assay
D,L-hydroxynorvaline 0.11 +/- 0.05 0.46 +/- 0.09 Coupled Assay
L-serine 0.31 +/- 0.02 0.29 +/- 0.05 Coupled Assay
k
cat
 (-min) K
m
 (mM) Method1
Table 8: Relative activity of TsaC mutants
1) Relative activities were determined by comparing mutant activities to the wild 
type protein.  2) -ND- represents no activity detected, indicating that no TC-AMP 
was formed by the R52A mutant.
Table 9: Size exclusion chromatography of t6A proteins
1) Proteins indicates the proteins present in the size exclusion experiment.  2) 
Expected mass indicates the mass of a 1:1 presence of all proteins in a 
heteromeric structure in kilodaltons.  3) Apparent MM indicates the determined 
apparent molecular masses from size exclusion experiments.  Weights separated
by commas indicate more then one retention peak was found.
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TsaC Predicted Significance
Wild Type 100.0% Standard
K53A 20.0% ATP Binding
R110A 57.9% ATP Binding
K50A 17.2% Phosphate coordination
N141A 14.5% ATP Binding
R52A Phosphate coordination
Relative Activity1
-ND-2
TsaDBCE 107.8 144.9, 97.4, 48.5, 22.1
TsaDBC 91.0 57.2, 23.3
TsaDBE 87.2 126.5, 45.6, 21.2
TsaDCE 82.6 156.2, 95.4, 47.9
TsaBCE 62.7 53.5, 20.9
TsaDB 70.3 151.4, 99.6, 50.6
TsaDC 65.8 243.8, 127.1, 44.2, 21.8
TsaDE 62.0 127.6, 46.1, 24.1
TsaBC 45.8 61.1, 23.5
TsaBE 42.0 53.9, 22.6
TsaCE 37.5 47.2, 22.3
TsaE homodimer 33.7 45.6, 21.5
TsaB homodimer 50.4 56.9
Proteins1 Expected Mass (kDa)2 Apparent MM (kDA) of Peaks3
Figure 1: Secondary structure of tRNA
Secondary structure of E. coli tRNALys(UUU) represented by a clover leaf.  The 
anticodon stem loop is colored in green, the D stem and loop is orange, the T 
stem and loop is gray, the aminoacyl stem is blue, and the variable loop is pink.  
Modified nucleoside abbreviations: D (dihydrouridine), mnm5s2U (5-
methylaminomethyl-2-thiouridine), t6A (N6-threonylcarbamoyl adenosine), T 
(thymine), acp3U (3-(3-amino-3-carboxypropyl)uridine), m7G (7-
methylguanosine), and ψ (pseudouridine).
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Figure 2: Tertiary structure of tRNA
Crystal structure of yeast tRNAPhe.  Location of aminoacylation and the anticodon 
are indicated. The anticodon stem and loop is colored yellow.  The acceptor stem
is colored blue.  The D stem and loop is colored orange. The T stem and loop is 
colored gray.  The variable loop is colored pink.  Image produced from PDB entry
4TNA (4).
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Aminoacylation 
Site
Anticodon
Figure 3: Canonical role of tRNA in translation
Amino acids are depicted as green circles.  The ribosome is shown in blue.
1) An aminoacylated tRNA binds to the aminoacyl (A) site of the ribosome in a 
sequence specific manner based on codon-anticodon interactions.  2) The 
growing peptide chain found bound to tRNA in the peptidyl (P) site is transferred 
to the amino acid of the aminoacyl-tRNA prompting transfer from the A to P sites.
3) With every sequential addition of an amino acid the tRNA found in the P site is 
transferred to the Exit (E Site) before leaving the ribosome as a uncharged tRNA.
4) The direction of ribosome movement along the mRNA.
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Figure 4: Simple and hyper-modifications of nucleosides
Examples of canonical bases, simple modifications, and hyper-modifications.  A) 
Adenosine serves as the starting nucleotide for both B) inosine and C) 2-
methylthio-N6-threonylcarbamoyl adenosine (ms2t6A).  Inosine is produced by the 
deamination of the exocyclic amine.  ms2t6A is produced by the addition of a 
carbamoylthreonyl group to the exocyclic amine and a methylthio moiety to the 2'
ring carbon.  D) Guanosine is the starting material for both E) 1-methyl 
guanosine and F) Wybutosine.  1-methyl guanosine is produced by a methyl 
addition.  Wytbutosine is produced by methylation, tricyclization, and addition 
reactions.
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Figure 5: Wobble base pairing
Examples of canonical (A:U and G:C) and some wobble base pairings.  Bases 
are denoted by their one letter abbreviations (bold).  Abbreviations: A=adeonsine,
G=guanosine, C=cytidine, U=uridine, I=inosine.
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Figure 6: Canonical and non-canonical roles of tRNA 
Uncharged tRNA play critical roles in gene expression and regulation of cellular 
death.  Gene expression is primarily regulated by uncharged-tRNA binding either 
nucleic acids or activating/deactivating enzymes.  The generation of tRNA 
fragments occurs through a variety of endonucleases (Dicer, RNaseP/Z, etc) and
are postulated to inhibit translation and act as small non-coding RNAs.  
Regulation of cell death is primarily mediated through cytochrome interactions.  
Aminoacylated tRNA serve their canonical role in protein synthesis as well as a 
variety of amino acid addition reactions (cell walls/membranes, peptide labeling, 
antibiotics etc) and aminoacylated tRNA dependent pathways (tetrapyrrole, tRNA
mischarging etc).  Image reproduced from (32).  Image of tRNA produced from 
PDB entry 4TNA (4).
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Figure 7: Structure of t6A and substrates implicated in its biosynthesis
Pioneering work completed in the 1970s identified the formation of t6A to be 
dependent upon L-threonine, bicarbonate, and ATP.
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Figure 8: Structure of an ASL containing t6A
Crystal structure of human tRNALys(UUU) ASL (blue) bound to the 16S ribosomal 
subunit with mRNA (purple).  The t6A37  base is colored green. Image reproduced 
from PDB entry 1MXQ (54).
77
A
1
A
2
A
3
Codon
U
34
U
35
U
36
t6A
37
ASL
Figure 9: TobZ is comprised of both TsaC and TsaD like domains
The TobZ protein contains both YrdC (TsaC) and Kae1 (TsaD) like domains and 
performs chemistry similar to what is expected for the t6A biosynthetic pathway.  
Image was taken from (62).
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Figure 10: Chemistry catalyzed by TobZ 
In the first step the TsaC like domain catalyzes the transfer of an activated 
carbamoyl (carbamoyl phosphate) to adenosine monophosphate.  Subsequently, 
adenosine monophosphate is used as an activating group to transfer the 
carbamoyl group to a sugar by the TsaD like domain.
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Figure 11: Analysis of yeast tRNA in sua5 and kae1 knockout strains 
Analysis of yeast sua5 (A-D) and kae1 (E-F) knockout strains.  A) Wild type 
trace, t6A present.  B) sua5 (tsaC) knockout strain t6A deficient.  C) sua5 
knockout with sua5 expressed in trans, t6A  production is rescued.  D) sua5 
knockout with E. coli tsaC expressed in trans t6A  production is rescued.  E) kae1 
(tsaD) knockout, t6A  absent.  F) kae1 knockout with kae1 expressed in trans, t6A 
production is rescued.  Figure was reproduced from (51, 52).
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Figure 12: Structure of N6-carbamoyladenosine modifications t6A, s6A, g6A, 
hn6A
N6-threonylcarbamoyl adenosine (t6A), N6-glycinylcarbamoyl adenosine (g6A), 
and N6-hydroxynorvalylcarbamoyl adenosine (hn6A) have been previously 
reported in yeast tRNA.  N6-serinylcarbamoyl adenosine (s6A) is a potential N6-
carbamoyladenosine nucleoside modification.
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Figure 13: Proposed chemistry of t6A formation
Activated indicates either adenosine monophosphate or phosphate.  The 
expected chemistry of t6A formation would initially occur through the activation of 
bicarbonate.  Subsequently, this activated bicarbonate could condense with 
either threonine or the exocyclic amine of adenosine.  If a N-carboxy-L-threonine 
adduct was formed a subsequent round of activation would be required before 
reacting with the exocyclic amine of adenosine.  If a carboxyadenosine adduct 
was formed activation would also be required before reaction with threonine.
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Figure 14: TsaC purification 
SDS-PAGE analysis of TsaC purification  
Lane 1, molecular weight marker.  
Lane 2, column flow through.  
Lane 3, column wash.  
Lane 4, 20 mM imidazole wash.  
Lane 5, 30 mM imidazole wash.  
Lane 6, 200 mM imidazole elution.
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Figure 15: SUMO-TsaD purification
A) SDS-PAGE analysis of SUMO-TsaD purification.  
Lane 1, flowthrough.  
Lane 2, 20 mM imidazole wash.  
Lane 3, 200 mM imidazole elution.  
Lane 4, molecular weight marker.  
B) Elution profile obtained from IEX of the SUMO-TsaD protein.  Fractions (0.5 
mL) were pooled and protein content was assessed by monitoring the 
absorbance at A260.  SUMO-TsaD was found in the fractions corresponding to the 
first major peak (6-9)  
C) SDS-PAGE showing purified SUMO-TsaD.  
Lane 1 molecular weight marker, 
Lane 2-5, purified SUMO-TsaD corresponding to fractions 6-9 from IEX.
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Figure 16: Clustering of bacterial yeaZ and yjeE with ygjD 
Select clustering of yeaZ (tsaB), yjeE (tsaE) and ygjD (tsaD) in bacterial 
genomes.  Image taken from (52).
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Figure 17: TsaB purification
SDS-PAGE analysis of expression and purification of TsaB.  
Lane 1, column flow through.  
Lane 2, column wash.  
Lane 3, 20 mM imidazole wash.  
Lane 4, 30 mM imidazole wash.  
Lane 5, 200 mM imidazole elution.  
Lane 6, molecular weight marker.
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Figure 18: TsaE purification 
SDS-PAGE analysis of expression and purification of TsaE.  
Lane 1, column flow through.  
Lane 2, column wash.  
Lane 3, 20 mM imidazole wash.  
Lane 4, 30 mM imidazole wash.  
Lane 5, 200 mM imidazole elution.  
Lane 6, molecular weight marker.
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Figure 19: RNA transcription and purification
Urea-PAGE (10%) gel.  RNA is visualized by placing the gel on a flourescent TLC
plate and exposing to a UV-light.  
Lane 1, tRNAIle(GAU) transcription.  
Lane 2, tRNAIle(CAU) transcription.  
Lane 3, tRNALys(UUU) transcription. 
The dye bromophenol blue (BPB) runs comparable to a 12 nucleotide RNA.
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Figure 20:  Proteins requirements for t6A formation in vitro
In vitro tRNA precipitation assays were performed in duplicate with [U-14C]-L-
threonine (left axis, black bars) or [14C]-bicarbonate (right axis, gray bars).  
Assays contain either all components or with indicated protein or ATP absent.  
Figure taken from (70).
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Figure 21: tRNA requirements of t6A formation
In vitro tRNA precipitation assays with [U-14C]-L-threonine (left axis, black bars) or
[14C]-bicarbonate (right axis, gray bars).  M. thermoautotrophicus tRNAGln(CUG), 
E. coli tRNALys(UUU), E. coli tRNAThr(GGU), and H. sapiens tRNALys -3(UUU) 
(ASL) were in vitro transcribed.  Δsua5 is unfractionated tRNA from Δsua5 yeast, 
and wt is unfractionated tRNA from wild-type yeast extract.  Figure taken from 
(70).
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Figure 22:  LC-MS of nucleosides derived from the t6A reaction
A) HPLC trace of digested in vitro transcribed E. coli tRNALys(UUU) before 
(bottom trace) and after (top trace) reaction with TsaC, TsaD, TsaB, and TsaE.  
B) Partial mass spectrum of compound eluting at ~ 9.9 minutes.  
Figure taken from (70).
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A
Figure 23: α-[32P]-ATP co-product analysis
A) tRNA absent. B) tRNA present.  Assay solutions were prepared as described 
in experimental with (+) inducting the presence and (-) the absence of each of the
specific components.  Lane 1 contains only α-[32P]-ATP as a standard.  Figures 
taken from (70).
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Figure 24: LC and LC-MS analysis of TC-AMP
A partial ion chromatogram showing the expected m/z TC-AMP, 491.10. The 
structure of TC-AMP and an LC trace showing the formation of a new peak when 
ATP, L-threonine and bicarbonate are reacted in the presence of TsaC are 
inserted into partial ion chromatogram.
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Figure 25: Non stoichiometric formation of AMP and TC-AMP
LC trace of the TsaC catalyzed conversion of ATP to TC-AMP.  The formation of 
TC-AMP occurs in significant excess to AMP, eliminating the potential of 2 ATPs 
being consumed to produce one TC-AMP.
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Figure 26: Proposed two step activation of TC-AMP
1) ATP and bicarbonate are converted to carboxyphosphate and ADP.  2) 
carboxyphosphate and L-threonine condense to form N-carboxy-L-threonine and 
phosphate.  3) N-carboxy-L-threonine and ADP condense to produce TC-AMP 
and phosphate.  The net equation of this reaction would be: ATP + bicarbonate + 
L-threonine → TC-AMP + 2 phosphate.
Figure 27: Proposed formation of TC-AMP using CO2
TsaC catalyzes the addition of CO2 to the amine of L-threonine to form carboxy-
L-threonine.  ATP activates carboxy-L-threonine to form TC-AMP and PPi.
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Figure 28: HPLC analysis of the formation of ATP from TC-AMP
Purified TC-AMP (blue trace), TsaC catalyzed ATP formation using 
pyrophosphate (red trace), TsaC catalyzed ATP formation using phosphate 
(yellow trace).
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Figure 29: Formation of ATP from TC-AMP catalyzed by TsaC 
Lane 1, α-[32P]-ATP standard.  
Lane 2, [32P]-PPi standard.  
Lane 3, reverse reaction using [32P]-PPi.  
Lane 4, α-[32P]-ATP standard.  
Lane 5, [32P]-PPi standard.  
Lane 6, reverse reaction using [32P]-Pi 
Lane 7, overloaded Pi standard.
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Figure 30: Formation of t6A from TC-AMP
tRNA precipitation assays were performed in duplicate with the following 
components: [U-14C]-L-threonine, TsaD, TsaB, TsaC, TsaE, ATP (A), [U-14C]-TC-
AMP, TsaD, TsaB, TsaC, TsaE, ATP (B), [U-14C]-TC-AMP, TsaD, TsaB, TsaE (C), 
[U-14C]-TC-AMP, TsaD, TsaB, TsaC, TsaE (D), [U-14C]-TC-AMP, TsaB, TsaC, TsaE
(E).  The reported DPM is an average of 2 experiments.
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Figure 31: pH profile of t6A formation
tRNA precipitation assays were performed in duplicate.  Velocity is reported in 
μM/min.  Error bars indicate the standard deviation of the assays.
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Figure 32: Steady state kinetics of the TsaC reaction (HPLC, L-threonine)
Assays were performed in duplicate.  Velocity is reported in μM/min. kcat was 
determined to be 0.063 +/- 0.005 -min.  Km was determined to be 1.4 +/- 0.5 mM.
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Figure 33: Steady state kinetics of the TsaC reaction (HPLC, ATP)
Assays were performed in duplicate.  Velocity is reported in μM/min. kcat was 
determined to be 0.039 +/- 0.003 -min.  Km was determined to be 0.11 +/- 0.04 
mM.
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Figure 34: UV trace of coupled assay
UV-VIS monitoring of the coupled assay.  Red trace, L-threonine was excluded 
from the reaction mixture, providing a background oxidation rate of NADH.  Black
trace, 100 μM pyrophosphate was added to determine the maximum rate of 
enzymatic conversion by the coupled enzymes.  Blue trace, TsaC reaction as 
described in experimental using 10 mM L-threonine.
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Figure 35: Steady state kinetics of the TsaC reaction (coupled assay, ATP)
Assays were performed in at least duplicate.  Velocity is reported in μM/min. kcat 
was determined to be 0.30 +/- 0.01 -min.  Km was determined to be 0.30 +/- 0.04 
mM.
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Figure 36: Steady state kinetics of the TsaC reaction (coupled assay, L-
threonine)
Assays were performed in duplicate.  Velocity is reported in μM/min. kcat was 
determined to be 0.25 +/- 0.009 -min.  Km was determined to be 0.33 +/- 0.05 
mM.
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Figure 37: Steady state kinetics of the TsaC reaction (coupled assay, L-
serine)
Assays were performed in duplicate.  Velocity is reported in μM/min. kcat was 
determined to be 0.31 +/- 0.02 -min.  Km was determined to be 0.29 +/- 0.05 mM.
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Figure 38: Steady state kinetics of the TsaC reaction (coupled assay, D,L-
hydroxynorvaline)
Assays were performed in duplicate.  Velocity is reported in μM/min. kcat was 
determined to be 0.11 +/- 0.05 -min.  Km was determined to be 0.46 +/- 0.09 mM.
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Figure 39: Solution structure of TsaC
Solution structure of TsaC derived from [U-15N, U-13C]-TsaC. PDB entry 2MX1 
(73).
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Figure 40: Crystal structure of S. tokodaii with TC-AMP bound
Crystal structure of S. tokodaii showing its surface.  TC-AMP and the residues 
which were mutated in E. coli are drawn as sticks. The image was produced 
using PDB entry 4E1B (62, 74).
The S. tokodaii residues are indicated on the crystal structure.  These residues 
correspond with E. coli as follows K57 (K50), R59 (R52), N63 (K53), R121 
(R110), and N145 (N141) as determined from an alignment between S. tokodaii 
Sua5 and E. coli YrdC (51).
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Figure 41: Analysis of protein interactions
SDS-PAGE analysis of protein interactions.  Proteins labeled in white contain a 
6x histidine tag.  Proteins labeled in black contain no histidine tag.  Lanes 1 and 
8 correspond to the protein molecular weight standards.  
Lane 2, non column bound fraction of the TsaC+TsaD protein incubation.  
Lane 3, column bound fraction of the TsaC+TsaD protein incubation.  
Lane 4, non column bound fraction of the TsaB+TsaD protein incubation.  
Lane 5, column bound fraction of the TsaB+TsaD protein incubation.  
Lane 6, non column bound fraction of the TsaB+TsaC protein incubation.  
Lane 7, column bound fraction of the TsaB+TsaC protein incubation.  
Lane 9, non column bound fraction of the TsaB+TsaE protein incubation.  
Lane 10, column bound fraction of the TsaB+TsaE protein incubation.
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Figure 42: Standard curve for determination of protein apparent mass
The Y-axis represents the log molecular weight.  The X-axis represents the 
eluted volume of standard divided by the excluded volume.
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Figure 43: Gel filtration of the proteins involved in t6A biosynthesis
Size exclusion chromatography (SEC) of individual proteins involved in t6A 
biosynthesis.  The Y-axis represents mAu while the X-axis represents time in 
minutes.  A) SEC of the TsaE protein. B) SEC of the TsaC protein.  C) SEC of the
TsaB protein.  D)  SEC of the TsaD protein.  E) Table summarizing the 
monomeric weight of proteins, and apparent molecular masses determined from 
SEC.
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Figure 44: Overlay of the TsaD, TsaB, and TsaD/TsaB gel filtration 
chromatograms
Red trace, TsaB.  Black trace, TsaD and TsaB.  Blue trace, TsaD.  A new peak is 
found when TsaB and TsaD are incubated together.  This peak corresponds to an
apparent molecular weight of 99.6 kDa.  The expected mass of a TsaD-TsaB 
heterodimer is 70.3 kDa while the expected mass of a TsaD-TsaBx2 trimer is 
95.6 kDa.
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Figure 45: LC analysis of TsaC Reaction with D,L-hydroxynorvaline
LC Trace of the TsaC reaction in the presence of D,L-hydroxynorvaline and
the structure of the putative product HNC-AMP.
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Figure 46: LC analysis of TsaC reaction with L-serine
LC Trace of the TsaC reaction in the presence of L-serine and the structure of the
putative product SC-AMP.
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Figure 47: LC analysis of TsaC reaction with glycine
LC Trace of the TsaC reaction in the presence of glycine and the structure of the 
putative product GC-AMP.
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Figure 48: Extracted ion chromatogram of peak eluting at 25.38 minutes
An ion with m/z of 447.067 was observed, consistent with the predicted m/z of 
447.07 (error of 5.79 ppm).  The ions corresponding to GC-AMP and AMP 
(346.05) are highlighted in yellow.
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Figure 49: Extracted ion chromatogram of peak eluting at 17.81 minutes
An ion with m/z of 477.08 was observed, consistent with the predicted m/z of 
477.08 (error of 0.16 ppm).  The ion corresponding to SC-AMP is highlighted in 
yellow.
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Figure 50: Extracted ion chromatogram of peak eluting at 18.2 minutes
An ion with m/z at 505.11 was observed, consistent with the predicted m/z of 
505.11 (error of 3.86 ppm for HNC-AMP).  The masses corresponding to HNC-
AMP and AMP (346.05) are highlighted in yellow.
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Figure 51: Incorporation of carbamoyladenosine derivatives into tRNA
Average background subtracted DPM of incorporation of two reactions are 
reported.  D,L-hydroxynorvaline, glycine and serine have incorporations slightly 
above background, but substantially less than 1.4% of the canonical substrate, L-
threonine.
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Figure 52: PrmC purification 
SDS-PAGE analysis of purification of PrmC.  
Lane 1, column wash.  
Lane 2, 20 mM imidazole wash.  
Lane 3, 30 mM imidazole wash.  
Lane 4, 200 mM imidazole elution.  
Lane 5, molecular weight marker.
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Figure 53: Biogenesis of N-carbamoyl-L-aspartate
The biochemical route to N-carbamoyl-L-aspartate.  1) ATP and bicarbonate are 
converted to carboxyphosphate and ADP.  2) The lone pair of ammonia attacks 
the carbonyl of carboxy phosphate producing carbamate and phosphate. 3) 
Carbmate is subsequently activated by ATP producing carbamoyl-phosphate and 
ADP.  4) The carbamoyl group of carbamoyl-phosphate is transferred to 
aspartate with the loss of phosphate producing N-carbamoyl aspartate (83).
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Figure 54: Biosynthetic pathway of t6A formation
TsaC catalyzes the formation of TC-AMP and PPi using L-threonine, CO2, and 
ATP.  The carbamoylthreonine moiety is transferred from AMP to the exocyclic 
amine of A37.  Bonds to the backbone of tRNA are indicated as R groups.
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Figure 55: Crystal structure of the TsaD-TsaB heterodimer
Crystal structure of the TsaD-TsaB heterodimer.  The solved structure was a 
tetramer comprised of two TsaD-TsaB heterodimers.  Red indicates the TsaD 
protein.  Blue indicates the TsaB protein. Taken produced from PDB entry 4YDU 
(84).
124
Figure 56: Crystal structure of the Kae1-Bud32-Cgi121 protein complex
Red Kae1-Bud32 fusion protein. Blue Cgi121.  Image produced from the PDB 
entry 3ENH (97).
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